<!doctype html><html><head><meta charset=utf-8><title>Vitamin D and Cancer</title>
<link rel=stylesheet href="/css/main.css?v=1748177531"><link rel=stylesheet href="/css/pagination.css?v=1748177531"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src=https://unpkg.com/lunr/lunr.js></script><script src=https://cdn.jsdelivr.net/npm/pako@2.1.0/dist/pako.min.js></script><script src="/js/search.js?v=1748177531"></script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>Vitamin D and Cancer</h1><time>February 2, 2024</time><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#vitamin-d-and-potential-effects-on-cancers-a-review>Vitamin D and potential effects on cancers: a review</a></li></ul></li></ul></li></ul></nav><hr><h4 id=vitamin-d-and-potential-effects-on-cancers-a-review>Vitamin D and potential effects on cancers: a review</h4><p>Mol Biol Rep. 2024 Jan 25;51(1):190. <a href=https://doi.org/10.1007/s11033-023-09111-y>doi: 10.1007/s11033-023-09111-y</a></p><p>PDF is behind a paywall. Can be viewed at <a href="https://www.deepdyve.com/lp/springer-journals/vitamin-d-and-potential-effects-on-cancers-a-review-BWuTgsGEGc?articleList=%2Fsearch%3Fquery%3D%2522Vitamin%2BD%2522%26articleFilter%3Drentable%257Cfree%257Crestricted%26dateFrom%3D2024-01-01%26page%3D2">DeepDyve</a></p><p>Pouria Sobhi 1, Mohammad Bahrami 1, Faraz Mahdizadeh 1, Aliakbar Fazaeli 2, Ghader Babaei 3, Lotfollah Rezagholizadeh 4</p><p><strong>Vitamin D is common to 4 concerns</strong></p><img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/png/role.png alt=image width=400><p>Cancer is characterized by the abnormal and uncontrollable division and growth of cells that can infiltrate tissues and alter normal physiological function, which will become crucial and life-threatening if left untreated. Cancer can be a result of genetics, such as mutations or environmental causes, including smoking, lack of physical activity, as well as nutritional imbalance in the body. Vitamin D is one of the foremost nutrients that play a crucial role in a variety of biochemical pathways, and it is an important key factor in several diseases. Vitamin D is an essential nutrient for preventing malignancies and a complementary treatment for cancer through direct and indirect biochemical pathways. In this article, we summarized the correlation between vitamin D and various cancers using an extensive search on PubMed, Google Scholar, and Scopus. This paper reviews the role of vitamin D in different types of cancer.</p><hr><h5 id=99-references>99 References</h5><ol><li><p>Christakos S et al (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39(2):243–253 (table of contents) - PubMed - PMC - DOI</p></li><li><p>Carlberg C (2019) Vitamin D: a micronutrient regulating genes. Curr Pharm Des 25(15):1740–1746 - PubMed - DOI</p></li><li><p>Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523(1):123–133 - PubMed - DOI</p></li><li><p>Akimbekov NS et al (2022) Vitamin D and phosphate interactions in health and disease. Adv Exp Med Biol 1362:37–46 - PubMed - DOI</p></li><li><p>Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930 - PubMed - DOI</p></li><li><p>Chang EM et al (2014) Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab 99(7):2526–2532 - PubMed - DOI</p></li><li><p>Zanatta L et al (2011) Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D3 in rat testis. Life Sci 89(15–16):515–523 - PubMed - DOI</p></li><li><p>Zhao D et al (2017) Serum vitamin D and sex hormones levels in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA). Maturitas 96:95–102 - PubMed - DOI</p></li><li><p>Bergengren O et al (2023) 2022 update on prostate <strong>cancer</strong> epidemiology and risk factors—a systematic review. Eur Urol 84(2):191–206 - PubMed - DOI</p></li><li><p>Song ZY et al (2018) Circulating vitamin D level and mortality in prostate <strong>cancer</strong> patients: a dose-response meta-analysis. Endocr Connect 7(12):R294–R303 - PubMed - PMC - DOI</p></li><li><p>Capiod T et al (2018) Do dietary calcium and vitamin D matter in men with prostate <strong>cancer</strong> ? Nat Rev Urol 15(7):453–461 - PubMed - DOI</p></li><li><p>Bao BY, Yeh SD, Lee YF (2006) 1alpha,25-dihydroxyvitamin D3 inhibits prostate <strong>cancer</strong> cell invasion via modulation of selective proteases. Carcinogenesis 27(1):32–42 - PubMed - DOI</p></li><li><p>Woo TC et al (2005) Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr <strong>cancer</strong> 51(1):32–36 - PubMed - DOI</p></li><li><p>Bernichtein S et al (2017) Vitamin D3 prevents calcium-induced progression of early-stage prostate tumors by counteracting TRPC6 and calcium sensing receptor upregulation. <strong>cancer</strong> Res 77(2):355–365 - PubMed - DOI</p></li><li><p>Barreto AM et al (2000) 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. <strong>cancer</strong> Epidemiol Biomarkers Prev 9(3):265–270 - PubMed</p></li><li><p>Gupta D et al (2009) Vitamin D and prostate <strong>cancer</strong> risk: a review of the epidemiological literature. Prostate <strong>cancer</strong> Prostatic Dis 12(3):215–226 - PubMed - DOI</p></li><li><p>Tuohimaa P et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate <strong>cancer</strong> risk: a longitudinal, nested case-control study in the Nordic countries. Int J <strong>cancer</strong> 108(1):104–108 - PubMed - DOI</p></li><li><p>Gao J et al (2018) Circulating vitamin D concentration and risk of prostate <strong>cancer</strong> : a dose-response meta-analysis of prospective studies. Ther Clin Risk Manag 14:95–104 - PubMed - PMC - DOI</p></li><li><p>Wilkinson L, Gathani T (2022) Understanding breast <strong>cancer</strong> as a global health concern. Br J Radiol 95(1130):20211033 - PubMed - DOI</p></li><li><p>Mittal MK et al (2008) In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 372(1):30–34 - PubMed - PMC - DOI</p></li><li><p>Liu X et al (2018) miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast <strong>cancer</strong> . Oncogene 37(25):3426–3439 - PubMed - DOI</p></li><li><p>Larriba MJ, Garcia de Herreros A, Munoz A (2016) Vitamin D and the epithelial to mesenchymal transition. Stem Cells Int 2016:6213872 - PubMed - PMC - DOI</p></li><li><p>Lopes N et al (2012) 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast <strong>cancer</strong> cells by CDH1-promoter demethylation. Anti <strong>cancer</strong> Res 32(1):249–257 - PubMed</p></li><li><p>Wilmanski T et al (2016) 1alpha,25-dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231 cells in an in vitro model of breast to bone metastasis. Nutr <strong>cancer</strong> 68(7):1202–1209 - PubMed - PMC - DOI</p></li><li><p>Koli K, Keski-Oja J (2000) 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11(4):221–229 - PubMed</p></li><li><p>Li J et al (2021) Vitamin D regulates CXCL12/CXCR4 and epithelial-to-mesenchymal transition in a model of breast <strong>cancer</strong> metastasis to lung. Endocrinology. <a href=https://doi.org/10.1210/endocr/bqab049>https://doi.org/10.1210/endocr/bqab049</a> - DOI - PubMed - PMC</p></li><li><p>Anisiewicz A et al (2018) Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland <strong>cancer</strong> . Int J Oncol 52(1):103–126 - PubMed</p></li><li><p>Anisiewicz A et al (2019) Calcitriol analogues decrease lung metastasis but impair bone metabolism in aged ovariectomized mice bearing 4T1 mammary gland tumours. Aging Dis 10(5):977–991 - PubMed - PMC - DOI</p></li><li><p>Vanhevel J et al (2022) The role of vitamin D in breast <strong>cancer</strong> risk and progression. Endocr Relat <strong>cancer</strong> 29(2):R33–R55 - PubMed - DOI</p></li><li><p>Filip-Psurska B et al (2022) Vitamin D, Th17 lymphocytes, and breast <strong>cancer</strong> . <strong>cancer</strong> s 14(15):3649 - PubMed - PMC - DOI</p></li><li><p>Krishnan AV et al (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast <strong>cancer</strong> therapy. Endocrinology 151(1):32–42 - PubMed - DOI</p></li><li><p>Swami S et al (2011) Inhibitory effects of calcitriol on the growth of MCF-7 breast <strong>cancer</strong> xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm <strong>cancer</strong> 2(3):190–202 - PubMed - PMC - DOI</p></li><li><p>Vink-van Wijngaarden T et al (1994) Inhibition of breast <strong>cancer</strong> cell growth by combined treatment with vitamin D3 analogues and tamoxifen. <strong>cancer</strong> Res 54(21):5711–5717 - PubMed</p></li><li><p>Lim ST et al (2018) Synergistic anti <strong>cancer</strong> effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast <strong>cancer</strong> cells. Mol Med Rep 17(4):5581–5588 - PubMed - PMC</p></li><li><p>Friedrich M et al (2018) Effects of combined treatment with vitamin D and COX2 inhibitors on breast <strong>cancer</strong> cell lines. Anti <strong>cancer</strong> Res 38(2):1201–1207 - PubMed</p></li><li><p>Segovia-Mendoza M et al (2017) The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast <strong>cancer</strong> cells. Am J <strong>cancer</strong> Res 7(7):1486–1500 - PubMed - PMC</p></li><li><p>Tavera-Mendoza LE et al (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast <strong>cancer</strong> cells. Proc Natl Acad Sci USA 114(11):E2186–E2194 - PubMed - PMC - DOI</p></li><li><p>Estebanez N et al (2018) Vitamin D exposure and Risk of Breast <strong>cancer</strong> : a meta-analysis. Sci Rep 8(1):9039 - PubMed - PMC - DOI</p></li><li><p>Song D et al (2019) Vitamin D intake, blood vitamin D levels, and the risk of breast <strong>cancer</strong> : a dose-response meta-analysis of observational studies. Aging 11(24):12708–12732 - PubMed - PMC - DOI</p></li><li><p>Vaughan-Shaw PG et al (2017) The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on <strong>cancer</strong> outcome: systematic review and meta-analysis. Br J <strong>cancer</strong> 116(8):1092–1110 - PubMed - PMC - DOI</p></li><li><p>Hossain S et al (2019) Vitamin D and breast <strong>cancer</strong> : a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 30:170–184 - PubMed - PMC - DOI</p></li><li><p>Crew KD et al (2019) Randomized double-blind placebo-controlled biomarker modulation study of vitamin D supplementation in premenopausal women at high risk for breast <strong>cancer</strong> (SWOG S0812). <strong>cancer</strong> Prev Res 12(7):481–490 - DOI</p></li><li><p>Crew KD et al (2009) Association between plasma 25-hydroxyvitamin D and breast <strong>cancer</strong> risk. <strong>cancer</strong> Prev Res 2(6):598–604 - DOI</p></li><li><p>Qin B et al (2020) Intake of vitamin D and calcium, sun exposure, and risk of breast <strong>cancer</strong> subtypes among black women. Am J Clin Nutr 111(2):396–405 - PubMed - DOI</p></li><li><p>Manson JE et al (2019) Vitamin D supplements and prevention of <strong>cancer</strong> and cardiovascular disease. N Engl J Med 380(1):33–44 - PubMed - DOI</p></li><li><p>Chandler PD et al (2020) Effect of vitamin D3 supplements on development of advanced <strong>cancer</strong> : a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850 - PubMed - PMC - DOI</p></li><li><p>Lappe J et al (2017) Effect of vitamin D and calcium supplementation on <strong>cancer</strong> incidence in older women: a randomized clinical trial. JAMA 317(12):1234–1243 - PubMed - DOI</p></li><li><p>Scragg RKR (2019) Overview of results from the Vitamin D assessment (ViDA) study. J Endocrinol Investig 42(12):1391–1399 - DOI</p></li><li><p>Arnaout A et al (2019) Randomized window of opportunity trial evaluating high-dose vitamin D in breast <strong>cancer</strong> patients. Breast <strong>cancer</strong> Res Treat 178(2):347–356 - PubMed - DOI</p></li><li><p>Li Z et al (2021) Effect of vitamin D supplementation on risk of breast <strong>cancer</strong> : a systematic review and meta-analysis of randomized controlled trials. Front Nutr 8:655727 - PubMed - PMC - DOI</p></li><li><p>Voutsadakis IA (2021) Vitamin D baseline levels at diagnosis of breast <strong>cancer</strong> : A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 14(1):16–26 - PubMed - DOI</p></li><li><p>O’Brien KM et al (2018) Vitamin D, DNA methylation, and breast <strong>cancer</strong> . Breast <strong>cancer</strong> Res 20(1):70 - PubMed - PMC - DOI</p></li><li><p>Simmons KM et al (2015) Gene signatures of 1,25-dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem 116(8):1693–1711 - PubMed - PMC - DOI</p></li><li><p>O’Brien KM et al (2022) Vitamin D supplement use and risk of breast <strong>cancer</strong> by race-ethnicity. Epidemiology 33(1):37–47 - PubMed - PMC - DOI</p></li><li><p>Sheng L, Callen DF, Turner AG (2018) Vitamin D(3) signaling and breast <strong>cancer</strong> : insights from transgenic mouse models. J Steroid Biochem Mol Biol 178:348–353 - PubMed - DOI</p></li><li><p>Bauer SR et al (2013) Plasma vitamin D levels, menopause, and risk of breast <strong>cancer</strong> : dose-response meta-analysis of prospective studies. Medicine 92(3):123–131 - PubMed - PMC - DOI</p></li><li><p>Lewandowska A et al (2022) Risk factors for the diagnosis of colorectal <strong>cancer</strong> . Cancer Control 29:10732748211056692 - PubMed - PMC - DOI</p></li><li><p>Klampfer L (2014) Vitamin D and colon <strong>cancer</strong> . World J Gastrointest Oncol 6(11):430–437 - PubMed - PMC - DOI</p></li><li><p>Ferrer-Mayorga G et al (2019) Mechanisms of action of vitamin D in colon <strong>cancer</strong> . J Steroid Biochem Mol Biol 185:1–6 - PubMed - DOI</p></li><li><p>Khayami R et al (2022) Epigenomic effects of vitamin D in colorectal <strong>cancer</strong> . Epigenomics 14(19):1213–1228 - PubMed - DOI</p></li><li><p>Huang CY et al (2022) Bioactive vitamin D attenuates MED28-mediated cell growth and epithelial-mesenchymal transition in human colorectal <strong>cancer</strong> cells. Biomed Res Int 2022:2268818 - PubMed - PMC - DOI</p></li><li><p>Varghese JE (2020) Role of vitamin D3 on apoptosis and inflammatory-associated gene in colorectal <strong>cancer</strong> : an in vitro approach. J King Saud Univ Sci 32(6):2786–2789 - DOI</p></li><li><p>Lamprecht SA, Lipkin M (2003) Chemoprevention of colon <strong>cancer</strong> by calcium, vitamin D and folate: molecular mechanisms. Nat Rev <strong>cancer</strong> 3(8):601–614 - PubMed - DOI</p></li><li><p>Timar J, Ladanyi A (2022) Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci 23(10):5384 - PubMed - PMC - DOI</p></li><li><p>Branisteanu DE et al (2023) Differences and similarities in epidemiology and risk factors for cutaneous and uveal melanoma. Medicina 59(5):943 - PubMed - PMC - DOI</p></li><li><p>Zhou M et al (2016) Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387(10015):251–272 - PubMed - DOI</p></li><li><p>Veierod MB et al (2010) Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. <strong>cancer</strong> Epidemiol Biomarkers Prev 19(1):111–120 - PubMed - DOI</p></li><li><p>Gajos-Michniewicz A, Czyz M (2020) WNT signaling in melanoma. Int J Mol Sci 21(14):4852 - PubMed - PMC - DOI</p></li><li><p>Holstein TW (2012) The evolution of the Wnt pathway. Cold Spring Harb Perspect Biol 4(7):a007922 - PubMed - PMC - DOI</p></li><li><p>Chaiprasongsuk A et al (2019) Protective effects of novel derivatives of vitamin D(3) and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms. Redox Biol 24:101206 - PubMed - PMC - DOI</p></li><li><p>Liyanage UE et al (2020) Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study. Br J Dermatol 182(1):97–103 - PubMed - DOI</p></li><li><p>Millen AE et al (2004) Diet and melanoma in a case-control study. <strong>cancer</strong> Epidemiol Biomark Prev 13(6):1042–1051 - DOI</p></li><li><p>van der Pols JC et al (2013) Vitamin D status and skin <strong>cancer</strong> risk independent of time outdoors: 11-year prospective study in an Australian community. J Investig Dermatol 133(3):637–641 - PubMed - DOI</p></li><li><p>Saiag P et al (2015) Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl <strong>cancer</strong> Inst 107(12):djv264 - PubMed - DOI</p></li><li><p>Muralidhar S et al (2019) Vitamin D-VDR signaling inhibits Wnt/β-catenin-mediated melanoma progression and promotes antitumor immunity. <strong>cancer</strong> Res 79(23):5986–5998 - PubMed - DOI</p></li><li><p>Becker AL et al (2021) The role of the vitamin D receptor in the pathogenesis, prognosis, and treatment of cutaneous melanoma. Front Oncol 11:743667 - PubMed - PMC - DOI</p></li><li><p>Tang JY et al (2011) Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin <strong>cancer</strong> : post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol 29(22):3078–3084 - PubMed - PMC - DOI</p></li><li><p>Vasilovici AF et al (2019) Vitamin D receptor polymorphisms and melanoma. Oncol Lett 17(5):4162–4169 - PubMed</p></li><li><p>Birke M et al (2020) Association of vitamin D receptor gene polymorphisms with melanoma risk: a meta-analysis and systematic review. Anti <strong>cancer</strong> Res 40(2):583–595 - PubMed - DOI</p></li><li><p>Samant H, Amiri HS, Zibari GB (2021) Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol 12(Suppl 2):S361–S373 - PubMed - PMC - DOI</p></li><li><p>McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13 - PubMed - DOI</p></li><li><p>Provvisiero DP et al (2019) Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit. Sci Rep 9(1):11695 - PubMed - PMC - DOI</p></li><li><p>Huang J et al (2016) 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Mol Med Rep 13(2):1373–1380 - PubMed - DOI</p></li><li><p>Hamilton JP et al (2014) Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma. Hepatol Res 44(13):1357–1366 - PubMed - PMC - DOI</p></li><li><p>Chen J et al (2016) Vitamin D deficiency promotes liver tumor growth in transforming growth factor-beta/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci Rep 6:30217 - PubMed - PMC - DOI</p></li><li><p>Gilliland DG, Jordan CT, Felix CA (2004) The molecular basis of leukemia. Hematol Am Soc Hematol Educ Progr 2004(1):80–97 - DOI</p></li><li><p>Lee HJ et al (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. <strong>cancer</strong> 120(4):521–529 - PubMed - DOI</p></li><li><p>Jackmann N et al (2020) Vitamin D status in children with leukemia, its predictors, and association with outcome. Pediatr Blood <strong>cancer</strong> 67(4):e28163 - PubMed - DOI</p></li><li><p>Wang J et al (2008) Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 283(37):25596–25605 - PubMed - DOI</p></li><li><p>Kricker A et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J <strong>cancer</strong> 122(1):144–154 - PubMed - DOI</p></li><li><p>Shanafelt TD et al (2011) Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117(5):1492–1498 - PubMed - PMC - DOI</p></li><li><p>Gediz F et al (2020) A possible connection between circulating 25-hydroxy-vitamin D and molecular response in chronic myeloid leukemia. Bratisl Lek Listy 121(5):366–369 - PubMed</p></li><li><p>Lokeshwar BL et al (1999) Inhibition of prostate <strong>cancer</strong> metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. <strong>cancer</strong> Epidemiol Biomarkers Prev 8(3):241–248 - PubMed</p></li><li><p>Chen Y et al (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288(27):19450–19458 - PubMed - PMC - DOI</p></li><li><p>Kristal AR et al (2014) Plasma vitamin D and prostate <strong>cancer</strong> risk: results from the Selenium and Vitamin E <strong>cancer</strong> Prevention Trial. <strong>cancer</strong> Epidemiol Biomarkers Prev 23(8):1494–1504 - PubMed - PMC - DOI</p></li><li><p>Jiang X et al (2019) Circulating vitamin D concentrations and risk of breast and prostate <strong>cancer</strong> : a Mendelian randomization study. Int J Epidemiol 48(5):1416–1424 - PubMed - DOI</p></li><li><p>Albanes D et al (2011) Serum 25-hydroxy vitamin D and prostate <strong>cancer</strong> risk in a large nested case-control study. <strong>cancer</strong> Epidemiol Biomarkers Prev 20(9):1850–1860 - PubMed - PMC - DOI</p></li><li><p>Protiva P et al (2016) Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial. Am J Clin Nutr 103(5):1224–1231 - PubMed - PMC - DOI</p></li><li><p>Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Mol Oncol 5(2):197–214 - PubMed - PMC - DOI</p></li></ol><pre style=background-color:#e0e0e0;white-space:pre-wrap>
<code class=language-text>
Markdown:
--------
{{&lt; toc &gt;}}

---

#### Vitamin D and potential effects on cancers: a review

Mol Biol Rep. 2024 Jan 25;51(1):190. [doi: 10.1007/s11033-023-09111-y](https://doi.org/10.1007/s11033-023-09111-y) 

PDF is behind a paywall.  Can be viewed at [DeepDyve](https://www.deepdyve.com/lp/springer-journals/vitamin-d-and-potential-effects-on-cancers-a-review-BWuTgsGEGc?articleList=%2Fsearch%3Fquery%3D%2522Vitamin%2BD%2522%26articleFilter%3Drentable%257Cfree%257Crestricted%26dateFrom%3D2024-01-01%26page%3D2)

Pouria Sobhi 1, Mohammad Bahrami 1, Faraz Mahdizadeh 1, Aliakbar Fazaeli 2, Ghader Babaei 3, Lotfollah Rezagholizadeh 4

 **Vitamin D is common to 4 concerns** 

&lt;img src=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/png/role.png&quot; alt=&quot;image&quot; width=&quot;400&quot;&gt;

Cancer is characterized by the abnormal and uncontrollable division and growth of cells that can infiltrate tissues and alter normal physiological function, which will become crucial and life-threatening if left untreated. Cancer can be a result of genetics, such as mutations or environmental causes, including smoking, lack of physical activity, as well as nutritional imbalance in the body. Vitamin D is one of the foremost nutrients that play a crucial role in a variety of biochemical pathways, and it is an important key factor in several diseases. Vitamin D is an essential nutrient for preventing malignancies and a complementary treatment for cancer through direct and indirect biochemical pathways. In this article, we summarized the correlation between vitamin D and various cancers using an extensive search on PubMed, Google Scholar, and Scopus. This paper reviews the role of vitamin D in different types of cancer.

---

##### 99 References

1. Christakos S et al (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39(2):243–253 (table of contents) - PubMed - PMC - DOI

1. Carlberg C (2019) Vitamin D: a micronutrient regulating genes. Curr Pharm Des 25(15):1740–1746 - PubMed - DOI

1. Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523(1):123–133 - PubMed - DOI

1. Akimbekov NS et al (2022) Vitamin D and phosphate interactions in health and disease. Adv Exp Med Biol 1362:37–46 - PubMed - DOI

1. Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930 - PubMed - DOI

1. Chang EM et al (2014) Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab 99(7):2526–2532 - PubMed - DOI

1. Zanatta L et al (2011) Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D3 in rat testis. Life Sci 89(15–16):515–523 - PubMed - DOI

1. Zhao D et al (2017) Serum vitamin D and sex hormones levels in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA). Maturitas 96:95–102 - PubMed - DOI

1. Bergengren O et al (2023) 2022 update on prostate  **cancer**  epidemiology and risk factors—a systematic review. Eur Urol 84(2):191–206 - PubMed - DOI

1. Song ZY et al (2018) Circulating vitamin D level and mortality in prostate  **cancer**  patients: a dose-response meta-analysis. Endocr Connect 7(12):R294–R303 - PubMed - PMC - DOI

1. Capiod T et al (2018) Do dietary calcium and vitamin D matter in men with prostate  **cancer** ? Nat Rev Urol 15(7):453–461 - PubMed - DOI

1. Bao BY, Yeh SD, Lee YF (2006) 1alpha,25-dihydroxyvitamin D3 inhibits prostate  **cancer**  cell invasion via modulation of selective proteases. Carcinogenesis 27(1):32–42 - PubMed - DOI

1. Woo TC et al (2005) Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr  **cancer**  51(1):32–36 - PubMed - DOI

1. Bernichtein S et al (2017) Vitamin D3 prevents calcium-induced progression of early-stage prostate tumors by counteracting TRPC6 and calcium sensing receptor upregulation.  **cancer**  Res 77(2):355–365 - PubMed - DOI

1. Barreto AM et al (2000) 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.  **cancer**  Epidemiol Biomarkers Prev 9(3):265–270 - PubMed

1. Gupta D et al (2009) Vitamin D and prostate  **cancer**  risk: a review of the epidemiological literature. Prostate  **cancer**  Prostatic Dis 12(3):215–226 - PubMed - DOI

1. Tuohimaa P et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate  **cancer**  risk: a longitudinal, nested case-control study in the Nordic countries. Int J  **cancer**  108(1):104–108 - PubMed - DOI

1. Gao J et al (2018) Circulating vitamin D concentration and risk of prostate  **cancer** : a dose-response meta-analysis of prospective studies. Ther Clin Risk Manag 14:95–104 - PubMed - PMC - DOI

1. Wilkinson L, Gathani T (2022) Understanding breast  **cancer**  as a global health concern. Br J Radiol 95(1130):20211033 - PubMed - DOI

1. Mittal MK et al (2008) In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 372(1):30–34 - PubMed - PMC - DOI

1. Liu X et al (2018) miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast  **cancer** . Oncogene 37(25):3426–3439 - PubMed - DOI

1. Larriba MJ, Garcia de Herreros A, Munoz A (2016) Vitamin D and the epithelial to mesenchymal transition. Stem Cells Int 2016:6213872 - PubMed - PMC - DOI

1. Lopes N et al (2012) 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast  **cancer**  cells by CDH1-promoter demethylation. Anti **cancer**  Res 32(1):249–257 - PubMed

1. Wilmanski T et al (2016) 1alpha,25-dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231 cells in an in vitro model of breast to bone metastasis. Nutr  **cancer**  68(7):1202–1209 - PubMed - PMC - DOI

1. Koli K, Keski-Oja J (2000) 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11(4):221–229 - PubMed

1. Li J et al (2021) Vitamin D regulates CXCL12/CXCR4 and epithelial-to-mesenchymal transition in a model of breast  **cancer**  metastasis to lung. Endocrinology. https://doi.org/10.1210/endocr/bqab049 - DOI - PubMed - PMC

1. Anisiewicz A et al (2018) Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland  **cancer** . Int J Oncol 52(1):103–126 - PubMed

1. Anisiewicz A et al (2019) Calcitriol analogues decrease lung metastasis but impair bone metabolism in aged ovariectomized mice bearing 4T1 mammary gland tumours. Aging Dis 10(5):977–991 - PubMed - PMC - DOI

1. Vanhevel J et al (2022) The role of vitamin D in breast  **cancer**  risk and progression. Endocr Relat  **cancer**  29(2):R33–R55 - PubMed - DOI

1. Filip-Psurska B et al (2022) Vitamin D, Th17 lymphocytes, and breast  **cancer** .  **cancer** s 14(15):3649 - PubMed - PMC - DOI

1. Krishnan AV et al (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast  **cancer**  therapy. Endocrinology 151(1):32–42 - PubMed - DOI

1. Swami S et al (2011) Inhibitory effects of calcitriol on the growth of MCF-7 breast  **cancer**  xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm  **cancer**  2(3):190–202 - PubMed - PMC - DOI

1. Vink-van Wijngaarden T et al (1994) Inhibition of breast  **cancer**  cell growth by combined treatment with vitamin D3 analogues and tamoxifen.  **cancer**  Res 54(21):5711–5717 - PubMed

1. Lim ST et al (2018) Synergistic anti **cancer**  effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast  **cancer**  cells. Mol Med Rep 17(4):5581–5588 - PubMed - PMC

1. Friedrich M et al (2018) Effects of combined treatment with vitamin D and COX2 inhibitors on breast  **cancer**  cell lines. Anti **cancer**  Res 38(2):1201–1207 - PubMed

1. Segovia-Mendoza M et al (2017) The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast  **cancer**  cells. Am J  **cancer**  Res 7(7):1486–1500 - PubMed - PMC

1. Tavera-Mendoza LE et al (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast  **cancer**  cells. Proc Natl Acad Sci USA 114(11):E2186–E2194 - PubMed - PMC - DOI

1. Estebanez N et al (2018) Vitamin D exposure and Risk of Breast  **cancer** : a meta-analysis. Sci Rep 8(1):9039 - PubMed - PMC - DOI

1. Song D et al (2019) Vitamin D intake, blood vitamin D levels, and the risk of breast  **cancer** : a dose-response meta-analysis of observational studies. Aging 11(24):12708–12732 - PubMed - PMC - DOI

1. Vaughan-Shaw PG et al (2017) The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on  **cancer**  outcome: systematic review and meta-analysis. Br J  **cancer**  116(8):1092–1110 - PubMed - PMC - DOI

1. Hossain S et al (2019) Vitamin D and breast  **cancer** : a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 30:170–184 - PubMed - PMC - DOI

1. Crew KD et al (2019) Randomized double-blind placebo-controlled biomarker modulation study of vitamin D supplementation in premenopausal women at high risk for breast  **cancer**  (SWOG S0812).  **cancer**  Prev Res 12(7):481–490 - DOI

1. Crew KD et al (2009) Association between plasma 25-hydroxyvitamin D and breast  **cancer**  risk.  **cancer**  Prev Res 2(6):598–604 - DOI

1. Qin B et al (2020) Intake of vitamin D and calcium, sun exposure, and risk of breast  **cancer**  subtypes among black women. Am J Clin Nutr 111(2):396–405 - PubMed - DOI

1. Manson JE et al (2019) Vitamin D supplements and prevention of  **cancer**  and cardiovascular disease. N Engl J Med 380(1):33–44 - PubMed - DOI

1. Chandler PD et al (2020) Effect of vitamin D3 supplements on development of advanced  **cancer** : a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850 - PubMed - PMC - DOI

1. Lappe J et al (2017) Effect of vitamin D and calcium supplementation on  **cancer**  incidence in older women: a randomized clinical trial. JAMA 317(12):1234–1243 - PubMed - DOI

1. Scragg RKR (2019) Overview of results from the Vitamin D assessment (ViDA) study. J Endocrinol Investig 42(12):1391–1399 - DOI

1. Arnaout A et al (2019) Randomized window of opportunity trial evaluating high-dose vitamin D in breast  **cancer**  patients. Breast  **cancer**  Res Treat 178(2):347–356 - PubMed - DOI

1. Li Z et al (2021) Effect of vitamin D supplementation on risk of breast  **cancer** : a systematic review and meta-analysis of randomized controlled trials. Front Nutr 8:655727 - PubMed - PMC - DOI

1. Voutsadakis IA (2021) Vitamin D baseline levels at diagnosis of breast  **cancer** : A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 14(1):16–26 - PubMed - DOI

1. O’Brien KM et al (2018) Vitamin D, DNA methylation, and breast  **cancer** . Breast  **cancer**  Res 20(1):70 - PubMed - PMC - DOI

1. Simmons KM et al (2015) Gene signatures of 1,25-dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem 116(8):1693–1711 - PubMed - PMC - DOI

1. O’Brien KM et al (2022) Vitamin D supplement use and risk of breast  **cancer**  by race-ethnicity. Epidemiology 33(1):37–47 - PubMed - PMC - DOI

1. Sheng L, Callen DF, Turner AG (2018) Vitamin D(3) signaling and breast  **cancer** : insights from transgenic mouse models. J Steroid Biochem Mol Biol 178:348–353 - PubMed - DOI

1. Bauer SR et al (2013) Plasma vitamin D levels, menopause, and risk of breast  **cancer** : dose-response meta-analysis of prospective studies. Medicine 92(3):123–131 - PubMed - PMC - DOI

1. Lewandowska A et al (2022) Risk factors for the diagnosis of colorectal  **cancer** . Cancer Control 29:10732748211056692 - PubMed - PMC - DOI

1. Klampfer L (2014) Vitamin D and colon  **cancer** . World J Gastrointest Oncol 6(11):430–437 - PubMed - PMC - DOI

1. Ferrer-Mayorga G et al (2019) Mechanisms of action of vitamin D in colon  **cancer** . J Steroid Biochem Mol Biol 185:1–6 - PubMed - DOI

1. Khayami R et al (2022) Epigenomic effects of vitamin D in colorectal  **cancer** . Epigenomics 14(19):1213–1228 - PubMed - DOI

1. Huang CY et al (2022) Bioactive vitamin D attenuates MED28-mediated cell growth and epithelial-mesenchymal transition in human colorectal  **cancer**  cells. Biomed Res Int 2022:2268818 - PubMed - PMC - DOI

1. Varghese JE (2020) Role of vitamin D3 on apoptosis and inflammatory-associated gene in colorectal  **cancer** : an in vitro approach. J King Saud Univ Sci 32(6):2786–2789 - DOI

1. Lamprecht SA, Lipkin M (2003) Chemoprevention of colon  **cancer**  by calcium, vitamin D and folate: molecular mechanisms. Nat Rev  **cancer**  3(8):601–614 - PubMed - DOI

1. Timar J, Ladanyi A (2022) Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci 23(10):5384 - PubMed - PMC - DOI

1. Branisteanu DE et al (2023) Differences and similarities in epidemiology and risk factors for cutaneous and uveal melanoma. Medicina 59(5):943 - PubMed - PMC - DOI

1. Zhou M et al (2016) Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387(10015):251–272 - PubMed - DOI

1. Veierod MB et al (2010) Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi.  **cancer**  Epidemiol Biomarkers Prev 19(1):111–120 - PubMed - DOI

1. Gajos-Michniewicz A, Czyz M (2020) WNT signaling in melanoma. Int J Mol Sci 21(14):4852 - PubMed - PMC - DOI

1. Holstein TW (2012) The evolution of the Wnt pathway. Cold Spring Harb Perspect Biol 4(7):a007922 - PubMed - PMC - DOI

1. Chaiprasongsuk A et al (2019) Protective effects of novel derivatives of vitamin D(3) and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms. Redox Biol 24:101206 - PubMed - PMC - DOI

1. Liyanage UE et al (2020) Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study. Br J Dermatol 182(1):97–103 - PubMed - DOI

1. Millen AE et al (2004) Diet and melanoma in a case-control study.  **cancer**  Epidemiol Biomark Prev 13(6):1042–1051 - DOI

1. van der Pols JC et al (2013) Vitamin D status and skin  **cancer**  risk independent of time outdoors: 11-year prospective study in an Australian community. J Investig Dermatol 133(3):637–641 - PubMed - DOI

1. Saiag P et al (2015) Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl  **cancer**  Inst 107(12):djv264 - PubMed - DOI

1. Muralidhar S et al (2019) Vitamin D-VDR signaling inhibits Wnt/β-catenin-mediated melanoma progression and promotes antitumor immunity.  **cancer**  Res 79(23):5986–5998 - PubMed - DOI

1. Becker AL et al (2021) The role of the vitamin D receptor in the pathogenesis, prognosis, and treatment of cutaneous melanoma. Front Oncol 11:743667 - PubMed - PMC - DOI

1. Tang JY et al (2011) Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin  **cancer** : post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol 29(22):3078–3084 - PubMed - PMC - DOI

1. Vasilovici AF et al (2019) Vitamin D receptor polymorphisms and melanoma. Oncol Lett 17(5):4162–4169 - PubMed

1. Birke M et al (2020) Association of vitamin D receptor gene polymorphisms with melanoma risk: a meta-analysis and systematic review. Anti **cancer**  Res 40(2):583–595 - PubMed - DOI

1. Samant H, Amiri HS, Zibari GB (2021) Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol 12(Suppl 2):S361–S373 - PubMed - PMC - DOI

1. McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13 - PubMed - DOI

1. Provvisiero DP et al (2019) Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit. Sci Rep 9(1):11695 - PubMed - PMC - DOI

1. Huang J et al (2016) 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Mol Med Rep 13(2):1373–1380 - PubMed - DOI

1. Hamilton JP et al (2014) Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma. Hepatol Res 44(13):1357–1366 - PubMed - PMC - DOI

1. Chen J et al (2016) Vitamin D deficiency promotes liver tumor growth in transforming growth factor-beta/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci Rep 6:30217 - PubMed - PMC - DOI

1. Gilliland DG, Jordan CT, Felix CA (2004) The molecular basis of leukemia. Hematol Am Soc Hematol Educ Progr 2004(1):80–97 - DOI

1. Lee HJ et al (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia.  **cancer**  120(4):521–529 - PubMed - DOI

1. Jackmann N et al (2020) Vitamin D status in children with leukemia, its predictors, and association with outcome. Pediatr Blood  **cancer**  67(4):e28163 - PubMed - DOI

1. Wang J et al (2008) Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 283(37):25596–25605 - PubMed - DOI

1. Kricker A et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J  **cancer**  122(1):144–154 - PubMed - DOI

1. Shanafelt TD et al (2011) Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117(5):1492–1498 - PubMed - PMC - DOI

1. Gediz F et al (2020) A possible connection between circulating 25-hydroxy-vitamin D and molecular response in chronic myeloid leukemia. Bratisl Lek Listy 121(5):366–369 - PubMed

1. Lokeshwar BL et al (1999) Inhibition of prostate  **cancer**  metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.  **cancer**  Epidemiol Biomarkers Prev 8(3):241–248 - PubMed

1. Chen Y et al (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288(27):19450–19458 - PubMed - PMC - DOI

1. Kristal AR et al (2014) Plasma vitamin D and prostate  **cancer**  risk: results from the Selenium and Vitamin E  **cancer**  Prevention Trial.  **cancer**  Epidemiol Biomarkers Prev 23(8):1494–1504 - PubMed - PMC - DOI

1. Jiang X et al (2019) Circulating vitamin D concentrations and risk of breast and prostate  **cancer** : a Mendelian randomization study. Int J Epidemiol 48(5):1416–1424 - PubMed - DOI

1. Albanes D et al (2011) Serum 25-hydroxy vitamin D and prostate  **cancer**  risk in a large nested case-control study.  **cancer**  Epidemiol Biomarkers Prev 20(9):1850–1860 - PubMed - PMC - DOI

1. Protiva P et al (2016) Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial. Am J Clin Nutr 103(5):1224–1231 - PubMed - PMC - DOI

1. Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Mol Oncol 5(2):197–214 - PubMed - PMC - DOI


AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Vitamin D and potential effects on cancers: a review`
│   inner_content: `Vitamin D and potential effects on cancers: a review`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D and potential effects on cancers: a review`
│   │   inner_content: `Vitamin D and potential effects on cancers: a review`├── TextNode
│   full_match: `\nMol Biol Rep. 2024 Jan 25;51(1):190. `
│   inner_content: `\nMol Biol Rep. 2024 Jan 25;51(1):190. `├── DoiLinkNode
│   full_match: `doi: 10.1007/s11033-023-09111-y`
│   inner_content: `10.1007/s11033-023-09111-y`├── TextNode
│   full_match: ` \nPDF is behind a paywall.  Can be viewed at `
│   inner_content: ` \nPDF is behind a paywall.  Can be viewed at `├── LinkNode
│   full_match: `[https://www.deepdyve.com/lp/springer-journals/vitamin-d-and-potential-effects-on-cancers-a-review-BWuTgsGEGc?articleList=%2Fsearch%3Fquery%3D%2522Vitamin%2BD%2522%26articleFilter%3Drentable%257Cfree%257Crestricted%26dateFrom%3D2024-01-01%26page%3D2|DeepDyve]`
│   inner_content: `DeepDyve`
│   url: `https://www.deepdyve.com/lp/springer-journals/vitamin-d-and-potential-effects-on-cancers-a-review-BWuTgsGEGc?articleList=%2Fsearch%3Fquery%3D%2522Vitamin%2BD%2522%26articleFilter%3Drentable%257Cfree%257Crestricted%26dateFrom%3D2024-01-01%26page%3D2`
│   children:
│   ├── TextNode
│   │   full_match: `DeepDyve`
│   │   inner_content: `DeepDyve`├── TextNode
│   full_match: `\nPouria Sobhi 1, Mohammad Bahrami 1, Faraz Mahdizadeh 1, Aliakbar Fazaeli 2, Ghader Babaei 3, Lotfollah Rezagholizadeh 4\n\n`
│   inner_content: `\nPouria Sobhi 1, Mohammad Bahrami 1, Faraz Mahdizadeh 1, Aliakbar Fazaeli 2, Ghader Babaei 3, Lotfollah Rezagholizadeh 4\n\n`├── BoldNode
│   full_match: `__Vitamin D is common to 4 concerns__`
│   inner_content: `Vitamin D is common to 4 concerns`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D is common to 4 concerns`
│   │   inner_content: `Vitamin D is common to 4 concerns`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;20741&quot; width=&quot;400&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;20741&quot; width=&quot;400&quot;
│   │   type: attId
│   │   attId: 20741
│   │   width: 400├── TextNode
│   full_match: `\nCancer is characterized by the abnormal and uncontrollable division and growth of cells that can infiltrate tissues and alter normal physiological function, which will become crucial and life-threatening if left untreated. Cancer can be a result of genetics, such as mutations or environmental causes, including smoking, lack of physical activity, as well as nutritional imbalance in the body. Vitamin D is one of the foremost nutrients that play a crucial role in a variety of biochemical pathways, and it is an important key factor in several diseases. Vitamin D is an essential nutrient for preventing malignancies and a complementary treatment for cancer through direct and indirect biochemical pathways. In this article, we summarized the correlation between vitamin D and various cancers using an extensive search on PubMed, Google Scholar, and Scopus. This paper reviews the role of vitamin D in different types of cancer.`
│   inner_content: `\nCancer is characterized by the abnormal and uncontrollable division and growth of cells that can infiltrate tissues and alter normal physiological function, which will become crucial and life-threatening if left untreated. Cancer can be a result of genetics, such as mutations or environmental causes, including smoking, lack of physical activity, as well as nutritional imbalance in the body. Vitamin D is one of the foremost nutrients that play a crucial role in a variety of biochemical pathways, and it is an important key factor in several diseases. Vitamin D is an essential nutrient for preventing malignancies and a complementary treatment for cancer through direct and indirect biochemical pathways. In this article, we summarized the correlation between vitamin D and various cancers using an extensive search on PubMed, Google Scholar, and Scopus. This paper reviews the role of vitamin D in different types of cancer.`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!!99 References`
│   inner_content: `99 References`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `99 References`
│   │   inner_content: `99 References`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Christakos S et al (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39(2):243–253 (table of contents) - PubMed - PMC - DOI`
│   inner_content: `Christakos S et al (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39(2):243–253 (table of contents) - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Christakos S et al (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39(2):243–253 (table of contents) - PubMed - PMC - DOI`
│   │   inner_content: `Christakos S et al (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39(2):243–253 (table of contents) - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Carlberg C (2019) Vitamin D: a micronutrient regulating genes. Curr Pharm Des 25(15):1740–1746 - PubMed - DOI`
│   inner_content: `Carlberg C (2019) Vitamin D: a micronutrient regulating genes. Curr Pharm Des 25(15):1740–1746 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Carlberg C (2019) Vitamin D: a micronutrient regulating genes. Curr Pharm Des 25(15):1740–1746 - PubMed - DOI`
│   │   inner_content: `Carlberg C (2019) Vitamin D: a micronutrient regulating genes. Curr Pharm Des 25(15):1740–1746 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523(1):123–133 - PubMed - DOI`
│   inner_content: `Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523(1):123–133 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523(1):123–133 - PubMed - DOI`
│   │   inner_content: `Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523(1):123–133 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Akimbekov NS et al (2022) Vitamin D and phosphate interactions in health and disease. Adv Exp Med Biol 1362:37–46 - PubMed - DOI`
│   inner_content: `Akimbekov NS et al (2022) Vitamin D and phosphate interactions in health and disease. Adv Exp Med Biol 1362:37–46 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Akimbekov NS et al (2022) Vitamin D and phosphate interactions in health and disease. Adv Exp Med Biol 1362:37–46 - PubMed - DOI`
│   │   inner_content: `Akimbekov NS et al (2022) Vitamin D and phosphate interactions in health and disease. Adv Exp Med Biol 1362:37–46 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930 - PubMed - DOI`
│   inner_content: `Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930 - PubMed - DOI`
│   │   inner_content: `Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Chang EM et al (2014) Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab 99(7):2526–2532 - PubMed - DOI`
│   inner_content: `Chang EM et al (2014) Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab 99(7):2526–2532 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chang EM et al (2014) Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab 99(7):2526–2532 - PubMed - DOI`
│   │   inner_content: `Chang EM et al (2014) Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab 99(7):2526–2532 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Zanatta L et al (2011) Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D3 in rat testis. Life Sci 89(15–16):515–523 - PubMed - DOI`
│   inner_content: `Zanatta L et al (2011) Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D3 in rat testis. Life Sci 89(15–16):515–523 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zanatta L et al (2011) Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D3 in rat testis. Life Sci 89(15–16):515–523 - PubMed - DOI`
│   │   inner_content: `Zanatta L et al (2011) Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D3 in rat testis. Life Sci 89(15–16):515–523 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Zhao D et al (2017) Serum vitamin D and sex hormones levels in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA). Maturitas 96:95–102 - PubMed - DOI`
│   inner_content: `Zhao D et al (2017) Serum vitamin D and sex hormones levels in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA). Maturitas 96:95–102 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zhao D et al (2017) Serum vitamin D and sex hormones levels in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA). Maturitas 96:95–102 - PubMed - DOI`
│   │   inner_content: `Zhao D et al (2017) Serum vitamin D and sex hormones levels in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA). Maturitas 96:95–102 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bergengren O et al (2023) 2022 update on prostate __cancer__ epidemiology and risk factors—a systematic review. Eur Urol 84(2):191–206 - PubMed - DOI`
│   inner_content: `Bergengren O et al (2023) 2022 update on prostate __cancer__ epidemiology and risk factors—a systematic review. Eur Urol 84(2):191–206 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bergengren O et al (2023) 2022 update on prostate `
│   │   inner_content: `Bergengren O et al (2023) 2022 update on prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` epidemiology and risk factors—a systematic review. Eur Urol 84(2):191–206 - PubMed - DOI`
│   │   inner_content: ` epidemiology and risk factors—a systematic review. Eur Urol 84(2):191–206 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Song ZY et al (2018) Circulating vitamin D level and mortality in prostate __cancer__ patients: a dose-response meta-analysis. Endocr Connect 7(12):R294–R303 - PubMed - PMC - DOI`
│   inner_content: `Song ZY et al (2018) Circulating vitamin D level and mortality in prostate __cancer__ patients: a dose-response meta-analysis. Endocr Connect 7(12):R294–R303 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Song ZY et al (2018) Circulating vitamin D level and mortality in prostate `
│   │   inner_content: `Song ZY et al (2018) Circulating vitamin D level and mortality in prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` patients: a dose-response meta-analysis. Endocr Connect 7(12):R294–R303 - PubMed - PMC - DOI`
│   │   inner_content: ` patients: a dose-response meta-analysis. Endocr Connect 7(12):R294–R303 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Capiod T et al (2018) Do dietary calcium and vitamin D matter in men with prostate __cancer__? Nat Rev Urol 15(7):453–461 - PubMed - DOI`
│   inner_content: `Capiod T et al (2018) Do dietary calcium and vitamin D matter in men with prostate __cancer__? Nat Rev Urol 15(7):453–461 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Capiod T et al (2018) Do dietary calcium and vitamin D matter in men with prostate `
│   │   inner_content: `Capiod T et al (2018) Do dietary calcium and vitamin D matter in men with prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `? Nat Rev Urol 15(7):453–461 - PubMed - DOI`
│   │   inner_content: `? Nat Rev Urol 15(7):453–461 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bao BY, Yeh SD, Lee YF (2006) 1alpha,25-dihydroxyvitamin D3 inhibits prostate __cancer__ cell invasion via modulation of selective proteases. Carcinogenesis 27(1):32–42 - PubMed - DOI`
│   inner_content: `Bao BY, Yeh SD, Lee YF (2006) 1alpha,25-dihydroxyvitamin D3 inhibits prostate __cancer__ cell invasion via modulation of selective proteases. Carcinogenesis 27(1):32–42 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bao BY, Yeh SD, Lee YF (2006) 1alpha,25-dihydroxyvitamin D3 inhibits prostate `
│   │   inner_content: `Bao BY, Yeh SD, Lee YF (2006) 1alpha,25-dihydroxyvitamin D3 inhibits prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` cell invasion via modulation of selective proteases. Carcinogenesis 27(1):32–42 - PubMed - DOI`
│   │   inner_content: ` cell invasion via modulation of selective proteases. Carcinogenesis 27(1):32–42 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Woo TC et al (2005) Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr __cancer__ 51(1):32–36 - PubMed - DOI`
│   inner_content: `Woo TC et al (2005) Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr __cancer__ 51(1):32–36 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Woo TC et al (2005) Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr `
│   │   inner_content: `Woo TC et al (2005) Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 51(1):32–36 - PubMed - DOI`
│   │   inner_content: ` 51(1):32–36 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bernichtein S et al (2017) Vitamin D3 prevents calcium-induced progression of early-stage prostate tumors by counteracting TRPC6 and calcium sensing receptor upregulation. __cancer__ Res 77(2):355–365 - PubMed - DOI`
│   inner_content: `Bernichtein S et al (2017) Vitamin D3 prevents calcium-induced progression of early-stage prostate tumors by counteracting TRPC6 and calcium sensing receptor upregulation. __cancer__ Res 77(2):355–365 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bernichtein S et al (2017) Vitamin D3 prevents calcium-induced progression of early-stage prostate tumors by counteracting TRPC6 and calcium sensing receptor upregulation. `
│   │   inner_content: `Bernichtein S et al (2017) Vitamin D3 prevents calcium-induced progression of early-stage prostate tumors by counteracting TRPC6 and calcium sensing receptor upregulation. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Res 77(2):355–365 - PubMed - DOI`
│   │   inner_content: ` Res 77(2):355–365 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Barreto AM et al (2000) 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. __cancer__ Epidemiol Biomarkers Prev 9(3):265–270 - PubMed`
│   inner_content: `Barreto AM et al (2000) 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. __cancer__ Epidemiol Biomarkers Prev 9(3):265–270 - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Barreto AM et al (2000) 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. `
│   │   inner_content: `Barreto AM et al (2000) 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Epidemiol Biomarkers Prev 9(3):265–270 - PubMed`
│   │   inner_content: ` Epidemiol Biomarkers Prev 9(3):265–270 - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Gupta D et al (2009) Vitamin D and prostate __cancer__ risk: a review of the epidemiological literature. Prostate __cancer__ Prostatic Dis 12(3):215–226 - PubMed - DOI`
│   inner_content: `Gupta D et al (2009) Vitamin D and prostate __cancer__ risk: a review of the epidemiological literature. Prostate __cancer__ Prostatic Dis 12(3):215–226 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Gupta D et al (2009) Vitamin D and prostate `
│   │   inner_content: `Gupta D et al (2009) Vitamin D and prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` risk: a review of the epidemiological literature. Prostate `
│   │   inner_content: ` risk: a review of the epidemiological literature. Prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Prostatic Dis 12(3):215–226 - PubMed - DOI`
│   │   inner_content: ` Prostatic Dis 12(3):215–226 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Tuohimaa P et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate __cancer__ risk: a longitudinal, nested case-control study in the Nordic countries. Int J __cancer__ 108(1):104–108 - PubMed - DOI`
│   inner_content: `Tuohimaa P et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate __cancer__ risk: a longitudinal, nested case-control study in the Nordic countries. Int J __cancer__ 108(1):104–108 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Tuohimaa P et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate `
│   │   inner_content: `Tuohimaa P et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` risk: a longitudinal, nested case-control study in the Nordic countries. Int J `
│   │   inner_content: ` risk: a longitudinal, nested case-control study in the Nordic countries. Int J `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 108(1):104–108 - PubMed - DOI`
│   │   inner_content: ` 108(1):104–108 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Gao J et al (2018) Circulating vitamin D concentration and risk of prostate __cancer__: a dose-response meta-analysis of prospective studies. Ther Clin Risk Manag 14:95–104 - PubMed - PMC - DOI`
│   inner_content: `Gao J et al (2018) Circulating vitamin D concentration and risk of prostate __cancer__: a dose-response meta-analysis of prospective studies. Ther Clin Risk Manag 14:95–104 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Gao J et al (2018) Circulating vitamin D concentration and risk of prostate `
│   │   inner_content: `Gao J et al (2018) Circulating vitamin D concentration and risk of prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: a dose-response meta-analysis of prospective studies. Ther Clin Risk Manag 14:95–104 - PubMed - PMC - DOI`
│   │   inner_content: `: a dose-response meta-analysis of prospective studies. Ther Clin Risk Manag 14:95–104 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Wilkinson L, Gathani T (2022) Understanding breast __cancer__ as a global health concern. Br J Radiol 95(1130):20211033 - PubMed - DOI`
│   inner_content: `Wilkinson L, Gathani T (2022) Understanding breast __cancer__ as a global health concern. Br J Radiol 95(1130):20211033 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wilkinson L, Gathani T (2022) Understanding breast `
│   │   inner_content: `Wilkinson L, Gathani T (2022) Understanding breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` as a global health concern. Br J Radiol 95(1130):20211033 - PubMed - DOI`
│   │   inner_content: ` as a global health concern. Br J Radiol 95(1130):20211033 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Mittal MK et al (2008) In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 372(1):30–34 - PubMed - PMC - DOI`
│   inner_content: `Mittal MK et al (2008) In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 372(1):30–34 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Mittal MK et al (2008) In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 372(1):30–34 - PubMed - PMC - DOI`
│   │   inner_content: `Mittal MK et al (2008) In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 372(1):30–34 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Liu X et al (2018) miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast __cancer__. Oncogene 37(25):3426–3439 - PubMed - DOI`
│   inner_content: `Liu X et al (2018) miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast __cancer__. Oncogene 37(25):3426–3439 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Liu X et al (2018) miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast `
│   │   inner_content: `Liu X et al (2018) miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `. Oncogene 37(25):3426–3439 - PubMed - DOI`
│   │   inner_content: `. Oncogene 37(25):3426–3439 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Larriba MJ, Garcia de Herreros A, Munoz A (2016) Vitamin D and the epithelial to mesenchymal transition. Stem Cells Int 2016:6213872 - PubMed - PMC - DOI`
│   inner_content: `Larriba MJ, Garcia de Herreros A, Munoz A (2016) Vitamin D and the epithelial to mesenchymal transition. Stem Cells Int 2016:6213872 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Larriba MJ, Garcia de Herreros A, Munoz A (2016) Vitamin D and the epithelial to mesenchymal transition. Stem Cells Int 2016:6213872 - PubMed - PMC - DOI`
│   │   inner_content: `Larriba MJ, Garcia de Herreros A, Munoz A (2016) Vitamin D and the epithelial to mesenchymal transition. Stem Cells Int 2016:6213872 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lopes N et al (2012) 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast __cancer__ cells by CDH1-promoter demethylation. Anti__cancer__ Res 32(1):249–257 - PubMed`
│   inner_content: `Lopes N et al (2012) 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast __cancer__ cells by CDH1-promoter demethylation. Anti__cancer__ Res 32(1):249–257 - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lopes N et al (2012) 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast `
│   │   inner_content: `Lopes N et al (2012) 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` cells by CDH1-promoter demethylation. Anti`
│   │   inner_content: ` cells by CDH1-promoter demethylation. Anti`
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Res 32(1):249–257 - PubMed`
│   │   inner_content: ` Res 32(1):249–257 - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Wilmanski T et al (2016) 1alpha,25-dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231 cells in an in vitro model of breast to bone metastasis. Nutr __cancer__ 68(7):1202–1209 - PubMed - PMC - DOI`
│   inner_content: `Wilmanski T et al (2016) 1alpha,25-dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231 cells in an in vitro model of breast to bone metastasis. Nutr __cancer__ 68(7):1202–1209 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wilmanski T et al (2016) 1alpha,25-dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231 cells in an in vitro model of breast to bone metastasis. Nutr `
│   │   inner_content: `Wilmanski T et al (2016) 1alpha,25-dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231 cells in an in vitro model of breast to bone metastasis. Nutr `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 68(7):1202–1209 - PubMed - PMC - DOI`
│   │   inner_content: ` 68(7):1202–1209 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Koli K, Keski-Oja J (2000) 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11(4):221–229 - PubMed`
│   inner_content: `Koli K, Keski-Oja J (2000) 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11(4):221–229 - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Koli K, Keski-Oja J (2000) 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11(4):221–229 - PubMed`
│   │   inner_content: `Koli K, Keski-Oja J (2000) 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11(4):221–229 - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Li J et al (2021) Vitamin D regulates CXCL12/CXCR4 and epithelial-to-mesenchymal transition in a model of breast __cancer__ metastasis to lung. Endocrinology. https://doi.org/10.1210/endocr/bqab049 - DOI - PubMed - PMC`
│   inner_content: `Li J et al (2021) Vitamin D regulates CXCL12/CXCR4 and epithelial-to-mesenchymal transition in a model of breast __cancer__ metastasis to lung. Endocrinology. https://doi.org/10.1210/endocr/bqab049 - DOI - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Li J et al (2021) Vitamin D regulates CXCL12/CXCR4 and epithelial-to-mesenchymal transition in a model of breast `
│   │   inner_content: `Li J et al (2021) Vitamin D regulates CXCL12/CXCR4 and epithelial-to-mesenchymal transition in a model of breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` metastasis to lung. Endocrinology. https://doi.org/10.1210/endocr/bqab049 - DOI - PubMed - PMC`
│   │   inner_content: ` metastasis to lung. Endocrinology. https://doi.org/10.1210/endocr/bqab049 - DOI - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Anisiewicz A et al (2018) Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland __cancer__. Int J Oncol 52(1):103–126 - PubMed`
│   inner_content: `Anisiewicz A et al (2018) Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland __cancer__. Int J Oncol 52(1):103–126 - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Anisiewicz A et al (2018) Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland `
│   │   inner_content: `Anisiewicz A et al (2018) Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `. Int J Oncol 52(1):103–126 - PubMed`
│   │   inner_content: `. Int J Oncol 52(1):103–126 - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Anisiewicz A et al (2019) Calcitriol analogues decrease lung metastasis but impair bone metabolism in aged ovariectomized mice bearing 4T1 mammary gland tumours. Aging Dis 10(5):977–991 - PubMed - PMC - DOI`
│   inner_content: `Anisiewicz A et al (2019) Calcitriol analogues decrease lung metastasis but impair bone metabolism in aged ovariectomized mice bearing 4T1 mammary gland tumours. Aging Dis 10(5):977–991 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Anisiewicz A et al (2019) Calcitriol analogues decrease lung metastasis but impair bone metabolism in aged ovariectomized mice bearing 4T1 mammary gland tumours. Aging Dis 10(5):977–991 - PubMed - PMC - DOI`
│   │   inner_content: `Anisiewicz A et al (2019) Calcitriol analogues decrease lung metastasis but impair bone metabolism in aged ovariectomized mice bearing 4T1 mammary gland tumours. Aging Dis 10(5):977–991 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Vanhevel J et al (2022) The role of vitamin D in breast __cancer__ risk and progression. Endocr Relat __cancer__ 29(2):R33–R55 - PubMed - DOI`
│   inner_content: `Vanhevel J et al (2022) The role of vitamin D in breast __cancer__ risk and progression. Endocr Relat __cancer__ 29(2):R33–R55 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vanhevel J et al (2022) The role of vitamin D in breast `
│   │   inner_content: `Vanhevel J et al (2022) The role of vitamin D in breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` risk and progression. Endocr Relat `
│   │   inner_content: ` risk and progression. Endocr Relat `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 29(2):R33–R55 - PubMed - DOI`
│   │   inner_content: ` 29(2):R33–R55 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Filip-Psurska B et al (2022) Vitamin D, Th17 lymphocytes, and breast __cancer__. __cancer__s 14(15):3649 - PubMed - PMC - DOI`
│   inner_content: `Filip-Psurska B et al (2022) Vitamin D, Th17 lymphocytes, and breast __cancer__. __cancer__s 14(15):3649 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Filip-Psurska B et al (2022) Vitamin D, Th17 lymphocytes, and breast `
│   │   inner_content: `Filip-Psurska B et al (2022) Vitamin D, Th17 lymphocytes, and breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `. `
│   │   inner_content: `. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `s 14(15):3649 - PubMed - PMC - DOI`
│   │   inner_content: `s 14(15):3649 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Krishnan AV et al (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast __cancer__ therapy. Endocrinology 151(1):32–42 - PubMed - DOI`
│   inner_content: `Krishnan AV et al (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast __cancer__ therapy. Endocrinology 151(1):32–42 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Krishnan AV et al (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast `
│   │   inner_content: `Krishnan AV et al (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` therapy. Endocrinology 151(1):32–42 - PubMed - DOI`
│   │   inner_content: ` therapy. Endocrinology 151(1):32–42 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Swami S et al (2011) Inhibitory effects of calcitriol on the growth of MCF-7 breast __cancer__ xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm __cancer__ 2(3):190–202 - PubMed - PMC - DOI`
│   inner_content: `Swami S et al (2011) Inhibitory effects of calcitriol on the growth of MCF-7 breast __cancer__ xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm __cancer__ 2(3):190–202 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Swami S et al (2011) Inhibitory effects of calcitriol on the growth of MCF-7 breast `
│   │   inner_content: `Swami S et al (2011) Inhibitory effects of calcitriol on the growth of MCF-7 breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm `
│   │   inner_content: ` xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 2(3):190–202 - PubMed - PMC - DOI`
│   │   inner_content: ` 2(3):190–202 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Vink-van Wijngaarden T et al (1994) Inhibition of breast __cancer__ cell growth by combined treatment with vitamin D3 analogues and tamoxifen. __cancer__ Res 54(21):5711–5717 - PubMed`
│   inner_content: `Vink-van Wijngaarden T et al (1994) Inhibition of breast __cancer__ cell growth by combined treatment with vitamin D3 analogues and tamoxifen. __cancer__ Res 54(21):5711–5717 - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vink-van Wijngaarden T et al (1994) Inhibition of breast `
│   │   inner_content: `Vink-van Wijngaarden T et al (1994) Inhibition of breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` cell growth by combined treatment with vitamin D3 analogues and tamoxifen. `
│   │   inner_content: ` cell growth by combined treatment with vitamin D3 analogues and tamoxifen. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Res 54(21):5711–5717 - PubMed`
│   │   inner_content: ` Res 54(21):5711–5717 - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lim ST et al (2018) Synergistic anti__cancer__ effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast __cancer__ cells. Mol Med Rep 17(4):5581–5588 - PubMed - PMC`
│   inner_content: `Lim ST et al (2018) Synergistic anti__cancer__ effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast __cancer__ cells. Mol Med Rep 17(4):5581–5588 - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lim ST et al (2018) Synergistic anti`
│   │   inner_content: `Lim ST et al (2018) Synergistic anti`
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast `
│   │   inner_content: ` effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` cells. Mol Med Rep 17(4):5581–5588 - PubMed - PMC`
│   │   inner_content: ` cells. Mol Med Rep 17(4):5581–5588 - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Friedrich M et al (2018) Effects of combined treatment with vitamin D and COX2 inhibitors on breast __cancer__ cell lines. Anti__cancer__ Res 38(2):1201–1207 - PubMed`
│   inner_content: `Friedrich M et al (2018) Effects of combined treatment with vitamin D and COX2 inhibitors on breast __cancer__ cell lines. Anti__cancer__ Res 38(2):1201–1207 - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Friedrich M et al (2018) Effects of combined treatment with vitamin D and COX2 inhibitors on breast `
│   │   inner_content: `Friedrich M et al (2018) Effects of combined treatment with vitamin D and COX2 inhibitors on breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` cell lines. Anti`
│   │   inner_content: ` cell lines. Anti`
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Res 38(2):1201–1207 - PubMed`
│   │   inner_content: ` Res 38(2):1201–1207 - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Segovia-Mendoza M et al (2017) The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast __cancer__ cells. Am J __cancer__ Res 7(7):1486–1500 - PubMed - PMC`
│   inner_content: `Segovia-Mendoza M et al (2017) The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast __cancer__ cells. Am J __cancer__ Res 7(7):1486–1500 - PubMed - PMC`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Segovia-Mendoza M et al (2017) The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast `
│   │   inner_content: `Segovia-Mendoza M et al (2017) The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` cells. Am J `
│   │   inner_content: ` cells. Am J `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Res 7(7):1486–1500 - PubMed - PMC`
│   │   inner_content: ` Res 7(7):1486–1500 - PubMed - PMC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Tavera-Mendoza LE et al (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast __cancer__ cells. Proc Natl Acad Sci USA 114(11):E2186–E2194 - PubMed - PMC - DOI`
│   inner_content: `Tavera-Mendoza LE et al (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast __cancer__ cells. Proc Natl Acad Sci USA 114(11):E2186–E2194 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Tavera-Mendoza LE et al (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast `
│   │   inner_content: `Tavera-Mendoza LE et al (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` cells. Proc Natl Acad Sci USA 114(11):E2186–E2194 - PubMed - PMC - DOI`
│   │   inner_content: ` cells. Proc Natl Acad Sci USA 114(11):E2186–E2194 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Estebanez N et al (2018) Vitamin D exposure and Risk of Breast __cancer__: a meta-analysis. Sci Rep 8(1):9039 - PubMed - PMC - DOI`
│   inner_content: `Estebanez N et al (2018) Vitamin D exposure and Risk of Breast __cancer__: a meta-analysis. Sci Rep 8(1):9039 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Estebanez N et al (2018) Vitamin D exposure and Risk of Breast `
│   │   inner_content: `Estebanez N et al (2018) Vitamin D exposure and Risk of Breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: a meta-analysis. Sci Rep 8(1):9039 - PubMed - PMC - DOI`
│   │   inner_content: `: a meta-analysis. Sci Rep 8(1):9039 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Song D et al (2019) Vitamin D intake, blood vitamin D levels, and the risk of breast __cancer__: a dose-response meta-analysis of observational studies. Aging 11(24):12708–12732 - PubMed - PMC - DOI`
│   inner_content: `Song D et al (2019) Vitamin D intake, blood vitamin D levels, and the risk of breast __cancer__: a dose-response meta-analysis of observational studies. Aging 11(24):12708–12732 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Song D et al (2019) Vitamin D intake, blood vitamin D levels, and the risk of breast `
│   │   inner_content: `Song D et al (2019) Vitamin D intake, blood vitamin D levels, and the risk of breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: a dose-response meta-analysis of observational studies. Aging 11(24):12708–12732 - PubMed - PMC - DOI`
│   │   inner_content: `: a dose-response meta-analysis of observational studies. Aging 11(24):12708–12732 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Vaughan-Shaw PG et al (2017) The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on __cancer__ outcome: systematic review and meta-analysis. Br J __cancer__ 116(8):1092–1110 - PubMed - PMC - DOI`
│   inner_content: `Vaughan-Shaw PG et al (2017) The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on __cancer__ outcome: systematic review and meta-analysis. Br J __cancer__ 116(8):1092–1110 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vaughan-Shaw PG et al (2017) The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on `
│   │   inner_content: `Vaughan-Shaw PG et al (2017) The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` outcome: systematic review and meta-analysis. Br J `
│   │   inner_content: ` outcome: systematic review and meta-analysis. Br J `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 116(8):1092–1110 - PubMed - PMC - DOI`
│   │   inner_content: ` 116(8):1092–1110 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Hossain S et al (2019) Vitamin D and breast __cancer__: a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 30:170–184 - PubMed - PMC - DOI`
│   inner_content: `Hossain S et al (2019) Vitamin D and breast __cancer__: a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 30:170–184 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Hossain S et al (2019) Vitamin D and breast `
│   │   inner_content: `Hossain S et al (2019) Vitamin D and breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 30:170–184 - PubMed - PMC - DOI`
│   │   inner_content: `: a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 30:170–184 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Crew KD et al (2019) Randomized double-blind placebo-controlled biomarker modulation study of vitamin D supplementation in premenopausal women at high risk for breast __cancer__ (SWOG S0812). __cancer__ Prev Res 12(7):481–490 - DOI`
│   inner_content: `Crew KD et al (2019) Randomized double-blind placebo-controlled biomarker modulation study of vitamin D supplementation in premenopausal women at high risk for breast __cancer__ (SWOG S0812). __cancer__ Prev Res 12(7):481–490 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Crew KD et al (2019) Randomized double-blind placebo-controlled biomarker modulation study of vitamin D supplementation in premenopausal women at high risk for breast `
│   │   inner_content: `Crew KD et al (2019) Randomized double-blind placebo-controlled biomarker modulation study of vitamin D supplementation in premenopausal women at high risk for breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` (SWOG S0812). `
│   │   inner_content: ` (SWOG S0812). `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Prev Res 12(7):481–490 - DOI`
│   │   inner_content: ` Prev Res 12(7):481–490 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Crew KD et al (2009) Association between plasma 25-hydroxyvitamin D and breast __cancer__ risk. __cancer__ Prev Res 2(6):598–604 - DOI`
│   inner_content: `Crew KD et al (2009) Association between plasma 25-hydroxyvitamin D and breast __cancer__ risk. __cancer__ Prev Res 2(6):598–604 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Crew KD et al (2009) Association between plasma 25-hydroxyvitamin D and breast `
│   │   inner_content: `Crew KD et al (2009) Association between plasma 25-hydroxyvitamin D and breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` risk. `
│   │   inner_content: ` risk. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Prev Res 2(6):598–604 - DOI`
│   │   inner_content: ` Prev Res 2(6):598–604 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Qin B et al (2020) Intake of vitamin D and calcium, sun exposure, and risk of breast __cancer__ subtypes among black women. Am J Clin Nutr 111(2):396–405 - PubMed - DOI`
│   inner_content: `Qin B et al (2020) Intake of vitamin D and calcium, sun exposure, and risk of breast __cancer__ subtypes among black women. Am J Clin Nutr 111(2):396–405 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Qin B et al (2020) Intake of vitamin D and calcium, sun exposure, and risk of breast `
│   │   inner_content: `Qin B et al (2020) Intake of vitamin D and calcium, sun exposure, and risk of breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` subtypes among black women. Am J Clin Nutr 111(2):396–405 - PubMed - DOI`
│   │   inner_content: ` subtypes among black women. Am J Clin Nutr 111(2):396–405 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Manson JE et al (2019) Vitamin D supplements and prevention of __cancer__ and cardiovascular disease. N Engl J Med 380(1):33–44 - PubMed - DOI`
│   inner_content: `Manson JE et al (2019) Vitamin D supplements and prevention of __cancer__ and cardiovascular disease. N Engl J Med 380(1):33–44 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Manson JE et al (2019) Vitamin D supplements and prevention of `
│   │   inner_content: `Manson JE et al (2019) Vitamin D supplements and prevention of `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` and cardiovascular disease. N Engl J Med 380(1):33–44 - PubMed - DOI`
│   │   inner_content: ` and cardiovascular disease. N Engl J Med 380(1):33–44 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Chandler PD et al (2020) Effect of vitamin D3 supplements on development of advanced __cancer__: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850 - PubMed - PMC - DOI`
│   inner_content: `Chandler PD et al (2020) Effect of vitamin D3 supplements on development of advanced __cancer__: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chandler PD et al (2020) Effect of vitamin D3 supplements on development of advanced `
│   │   inner_content: `Chandler PD et al (2020) Effect of vitamin D3 supplements on development of advanced `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850 - PubMed - PMC - DOI`
│   │   inner_content: `: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lappe J et al (2017) Effect of vitamin D and calcium supplementation on __cancer__ incidence in older women: a randomized clinical trial. JAMA 317(12):1234–1243 - PubMed - DOI`
│   inner_content: `Lappe J et al (2017) Effect of vitamin D and calcium supplementation on __cancer__ incidence in older women: a randomized clinical trial. JAMA 317(12):1234–1243 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lappe J et al (2017) Effect of vitamin D and calcium supplementation on `
│   │   inner_content: `Lappe J et al (2017) Effect of vitamin D and calcium supplementation on `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` incidence in older women: a randomized clinical trial. JAMA 317(12):1234–1243 - PubMed - DOI`
│   │   inner_content: ` incidence in older women: a randomized clinical trial. JAMA 317(12):1234–1243 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Scragg RKR (2019) Overview of results from the Vitamin D assessment (ViDA) study. J Endocrinol Investig 42(12):1391–1399 - DOI`
│   inner_content: `Scragg RKR (2019) Overview of results from the Vitamin D assessment (ViDA) study. J Endocrinol Investig 42(12):1391–1399 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Scragg RKR (2019) Overview of results from the Vitamin D assessment (ViDA) study. J Endocrinol Investig 42(12):1391–1399 - DOI`
│   │   inner_content: `Scragg RKR (2019) Overview of results from the Vitamin D assessment (ViDA) study. J Endocrinol Investig 42(12):1391–1399 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Arnaout A et al (2019) Randomized window of opportunity trial evaluating high-dose vitamin D in breast __cancer__ patients. Breast __cancer__ Res Treat 178(2):347–356 - PubMed - DOI`
│   inner_content: `Arnaout A et al (2019) Randomized window of opportunity trial evaluating high-dose vitamin D in breast __cancer__ patients. Breast __cancer__ Res Treat 178(2):347–356 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Arnaout A et al (2019) Randomized window of opportunity trial evaluating high-dose vitamin D in breast `
│   │   inner_content: `Arnaout A et al (2019) Randomized window of opportunity trial evaluating high-dose vitamin D in breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` patients. Breast `
│   │   inner_content: ` patients. Breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Res Treat 178(2):347–356 - PubMed - DOI`
│   │   inner_content: ` Res Treat 178(2):347–356 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Li Z et al (2021) Effect of vitamin D supplementation on risk of breast __cancer__: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 8:655727 - PubMed - PMC - DOI`
│   inner_content: `Li Z et al (2021) Effect of vitamin D supplementation on risk of breast __cancer__: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 8:655727 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Li Z et al (2021) Effect of vitamin D supplementation on risk of breast `
│   │   inner_content: `Li Z et al (2021) Effect of vitamin D supplementation on risk of breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 8:655727 - PubMed - PMC - DOI`
│   │   inner_content: `: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 8:655727 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Voutsadakis IA (2021) Vitamin D baseline levels at diagnosis of breast __cancer__: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 14(1):16–26 - PubMed - DOI`
│   inner_content: `Voutsadakis IA (2021) Vitamin D baseline levels at diagnosis of breast __cancer__: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 14(1):16–26 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Voutsadakis IA (2021) Vitamin D baseline levels at diagnosis of breast `
│   │   inner_content: `Voutsadakis IA (2021) Vitamin D baseline levels at diagnosis of breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 14(1):16–26 - PubMed - DOI`
│   │   inner_content: `: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 14(1):16–26 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#O’Brien KM et al (2018) Vitamin D, DNA methylation, and breast __cancer__. Breast __cancer__ Res 20(1):70 - PubMed - PMC - DOI`
│   inner_content: `O’Brien KM et al (2018) Vitamin D, DNA methylation, and breast __cancer__. Breast __cancer__ Res 20(1):70 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `O’Brien KM et al (2018) Vitamin D, DNA methylation, and breast `
│   │   inner_content: `O’Brien KM et al (2018) Vitamin D, DNA methylation, and breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `. Breast `
│   │   inner_content: `. Breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Res 20(1):70 - PubMed - PMC - DOI`
│   │   inner_content: ` Res 20(1):70 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Simmons KM et al (2015) Gene signatures of 1,25-dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem 116(8):1693–1711 - PubMed - PMC - DOI`
│   inner_content: `Simmons KM et al (2015) Gene signatures of 1,25-dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem 116(8):1693–1711 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Simmons KM et al (2015) Gene signatures of 1,25-dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem 116(8):1693–1711 - PubMed - PMC - DOI`
│   │   inner_content: `Simmons KM et al (2015) Gene signatures of 1,25-dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem 116(8):1693–1711 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#O’Brien KM et al (2022) Vitamin D supplement use and risk of breast __cancer__ by race-ethnicity. Epidemiology 33(1):37–47 - PubMed - PMC - DOI`
│   inner_content: `O’Brien KM et al (2022) Vitamin D supplement use and risk of breast __cancer__ by race-ethnicity. Epidemiology 33(1):37–47 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `O’Brien KM et al (2022) Vitamin D supplement use and risk of breast `
│   │   inner_content: `O’Brien KM et al (2022) Vitamin D supplement use and risk of breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` by race-ethnicity. Epidemiology 33(1):37–47 - PubMed - PMC - DOI`
│   │   inner_content: ` by race-ethnicity. Epidemiology 33(1):37–47 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Sheng L, Callen DF, Turner AG (2018) Vitamin D(3) signaling and breast __cancer__: insights from transgenic mouse models. J Steroid Biochem Mol Biol 178:348–353 - PubMed - DOI`
│   inner_content: `Sheng L, Callen DF, Turner AG (2018) Vitamin D(3) signaling and breast __cancer__: insights from transgenic mouse models. J Steroid Biochem Mol Biol 178:348–353 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Sheng L, Callen DF, Turner AG (2018) Vitamin D(3) signaling and breast `
│   │   inner_content: `Sheng L, Callen DF, Turner AG (2018) Vitamin D(3) signaling and breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: insights from transgenic mouse models. J Steroid Biochem Mol Biol 178:348–353 - PubMed - DOI`
│   │   inner_content: `: insights from transgenic mouse models. J Steroid Biochem Mol Biol 178:348–353 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Bauer SR et al (2013) Plasma vitamin D levels, menopause, and risk of breast __cancer__: dose-response meta-analysis of prospective studies. Medicine 92(3):123–131 - PubMed - PMC - DOI`
│   inner_content: `Bauer SR et al (2013) Plasma vitamin D levels, menopause, and risk of breast __cancer__: dose-response meta-analysis of prospective studies. Medicine 92(3):123–131 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bauer SR et al (2013) Plasma vitamin D levels, menopause, and risk of breast `
│   │   inner_content: `Bauer SR et al (2013) Plasma vitamin D levels, menopause, and risk of breast `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: dose-response meta-analysis of prospective studies. Medicine 92(3):123–131 - PubMed - PMC - DOI`
│   │   inner_content: `: dose-response meta-analysis of prospective studies. Medicine 92(3):123–131 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lewandowska A et al (2022) Risk factors for the diagnosis of colorectal __cancer__. Cancer Control 29:10732748211056692 - PubMed - PMC - DOI`
│   inner_content: `Lewandowska A et al (2022) Risk factors for the diagnosis of colorectal __cancer__. Cancer Control 29:10732748211056692 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lewandowska A et al (2022) Risk factors for the diagnosis of colorectal `
│   │   inner_content: `Lewandowska A et al (2022) Risk factors for the diagnosis of colorectal `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `. Cancer Control 29:10732748211056692 - PubMed - PMC - DOI`
│   │   inner_content: `. Cancer Control 29:10732748211056692 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Klampfer L (2014) Vitamin D and colon __cancer__. World J Gastrointest Oncol 6(11):430–437 - PubMed - PMC - DOI`
│   inner_content: `Klampfer L (2014) Vitamin D and colon __cancer__. World J Gastrointest Oncol 6(11):430–437 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Klampfer L (2014) Vitamin D and colon `
│   │   inner_content: `Klampfer L (2014) Vitamin D and colon `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `. World J Gastrointest Oncol 6(11):430–437 - PubMed - PMC - DOI`
│   │   inner_content: `. World J Gastrointest Oncol 6(11):430–437 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Ferrer-Mayorga G et al (2019) Mechanisms of action of vitamin D in colon __cancer__. J Steroid Biochem Mol Biol 185:1–6 - PubMed - DOI`
│   inner_content: `Ferrer-Mayorga G et al (2019) Mechanisms of action of vitamin D in colon __cancer__. J Steroid Biochem Mol Biol 185:1–6 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Ferrer-Mayorga G et al (2019) Mechanisms of action of vitamin D in colon `
│   │   inner_content: `Ferrer-Mayorga G et al (2019) Mechanisms of action of vitamin D in colon `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `. J Steroid Biochem Mol Biol 185:1–6 - PubMed - DOI`
│   │   inner_content: `. J Steroid Biochem Mol Biol 185:1–6 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Khayami R et al (2022) Epigenomic effects of vitamin D in colorectal __cancer__. Epigenomics 14(19):1213–1228 - PubMed - DOI`
│   inner_content: `Khayami R et al (2022) Epigenomic effects of vitamin D in colorectal __cancer__. Epigenomics 14(19):1213–1228 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Khayami R et al (2022) Epigenomic effects of vitamin D in colorectal `
│   │   inner_content: `Khayami R et al (2022) Epigenomic effects of vitamin D in colorectal `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `. Epigenomics 14(19):1213–1228 - PubMed - DOI`
│   │   inner_content: `. Epigenomics 14(19):1213–1228 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Huang CY et al (2022) Bioactive vitamin D attenuates MED28-mediated cell growth and epithelial-mesenchymal transition in human colorectal __cancer__ cells. Biomed Res Int 2022:2268818 - PubMed - PMC - DOI`
│   inner_content: `Huang CY et al (2022) Bioactive vitamin D attenuates MED28-mediated cell growth and epithelial-mesenchymal transition in human colorectal __cancer__ cells. Biomed Res Int 2022:2268818 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Huang CY et al (2022) Bioactive vitamin D attenuates MED28-mediated cell growth and epithelial-mesenchymal transition in human colorectal `
│   │   inner_content: `Huang CY et al (2022) Bioactive vitamin D attenuates MED28-mediated cell growth and epithelial-mesenchymal transition in human colorectal `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` cells. Biomed Res Int 2022:2268818 - PubMed - PMC - DOI`
│   │   inner_content: ` cells. Biomed Res Int 2022:2268818 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Varghese JE (2020) Role of vitamin D3 on apoptosis and inflammatory-associated gene in colorectal __cancer__: an in vitro approach. J King Saud Univ Sci 32(6):2786–2789 - DOI`
│   inner_content: `Varghese JE (2020) Role of vitamin D3 on apoptosis and inflammatory-associated gene in colorectal __cancer__: an in vitro approach. J King Saud Univ Sci 32(6):2786–2789 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Varghese JE (2020) Role of vitamin D3 on apoptosis and inflammatory-associated gene in colorectal `
│   │   inner_content: `Varghese JE (2020) Role of vitamin D3 on apoptosis and inflammatory-associated gene in colorectal `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: an in vitro approach. J King Saud Univ Sci 32(6):2786–2789 - DOI`
│   │   inner_content: `: an in vitro approach. J King Saud Univ Sci 32(6):2786–2789 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lamprecht SA, Lipkin M (2003) Chemoprevention of colon __cancer__ by calcium, vitamin D and folate: molecular mechanisms. Nat Rev __cancer__ 3(8):601–614 - PubMed - DOI`
│   inner_content: `Lamprecht SA, Lipkin M (2003) Chemoprevention of colon __cancer__ by calcium, vitamin D and folate: molecular mechanisms. Nat Rev __cancer__ 3(8):601–614 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lamprecht SA, Lipkin M (2003) Chemoprevention of colon `
│   │   inner_content: `Lamprecht SA, Lipkin M (2003) Chemoprevention of colon `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` by calcium, vitamin D and folate: molecular mechanisms. Nat Rev `
│   │   inner_content: ` by calcium, vitamin D and folate: molecular mechanisms. Nat Rev `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 3(8):601–614 - PubMed - DOI`
│   │   inner_content: ` 3(8):601–614 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Timar J, Ladanyi A (2022) Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci 23(10):5384 - PubMed - PMC - DOI`
│   inner_content: `Timar J, Ladanyi A (2022) Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci 23(10):5384 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Timar J, Ladanyi A (2022) Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci 23(10):5384 - PubMed - PMC - DOI`
│   │   inner_content: `Timar J, Ladanyi A (2022) Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci 23(10):5384 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Branisteanu DE et al (2023) Differences and similarities in epidemiology and risk factors for cutaneous and uveal melanoma. Medicina 59(5):943 - PubMed - PMC - DOI`
│   inner_content: `Branisteanu DE et al (2023) Differences and similarities in epidemiology and risk factors for cutaneous and uveal melanoma. Medicina 59(5):943 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Branisteanu DE et al (2023) Differences and similarities in epidemiology and risk factors for cutaneous and uveal melanoma. Medicina 59(5):943 - PubMed - PMC - DOI`
│   │   inner_content: `Branisteanu DE et al (2023) Differences and similarities in epidemiology and risk factors for cutaneous and uveal melanoma. Medicina 59(5):943 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Zhou M et al (2016) Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387(10015):251–272 - PubMed - DOI`
│   inner_content: `Zhou M et al (2016) Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387(10015):251–272 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zhou M et al (2016) Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387(10015):251–272 - PubMed - DOI`
│   │   inner_content: `Zhou M et al (2016) Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387(10015):251–272 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Veierod MB et al (2010) Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. __cancer__ Epidemiol Biomarkers Prev 19(1):111–120 - PubMed - DOI`
│   inner_content: `Veierod MB et al (2010) Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. __cancer__ Epidemiol Biomarkers Prev 19(1):111–120 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Veierod MB et al (2010) Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. `
│   │   inner_content: `Veierod MB et al (2010) Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Epidemiol Biomarkers Prev 19(1):111–120 - PubMed - DOI`
│   │   inner_content: ` Epidemiol Biomarkers Prev 19(1):111–120 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Gajos-Michniewicz A, Czyz M (2020) WNT signaling in melanoma. Int J Mol Sci 21(14):4852 - PubMed - PMC - DOI`
│   inner_content: `Gajos-Michniewicz A, Czyz M (2020) WNT signaling in melanoma. Int J Mol Sci 21(14):4852 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Gajos-Michniewicz A, Czyz M (2020) WNT signaling in melanoma. Int J Mol Sci 21(14):4852 - PubMed - PMC - DOI`
│   │   inner_content: `Gajos-Michniewicz A, Czyz M (2020) WNT signaling in melanoma. Int J Mol Sci 21(14):4852 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Holstein TW (2012) The evolution of the Wnt pathway. Cold Spring Harb Perspect Biol 4(7):a007922 - PubMed - PMC - DOI`
│   inner_content: `Holstein TW (2012) The evolution of the Wnt pathway. Cold Spring Harb Perspect Biol 4(7):a007922 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Holstein TW (2012) The evolution of the Wnt pathway. Cold Spring Harb Perspect Biol 4(7):a007922 - PubMed - PMC - DOI`
│   │   inner_content: `Holstein TW (2012) The evolution of the Wnt pathway. Cold Spring Harb Perspect Biol 4(7):a007922 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Chaiprasongsuk A et al (2019) Protective effects of novel derivatives of vitamin D(3) and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms. Redox Biol 24:101206 - PubMed - PMC - DOI`
│   inner_content: `Chaiprasongsuk A et al (2019) Protective effects of novel derivatives of vitamin D(3) and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms. Redox Biol 24:101206 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chaiprasongsuk A et al (2019) Protective effects of novel derivatives of vitamin D(3) and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms. Redox Biol 24:101206 - PubMed - PMC - DOI`
│   │   inner_content: `Chaiprasongsuk A et al (2019) Protective effects of novel derivatives of vitamin D(3) and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms. Redox Biol 24:101206 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Liyanage UE et al (2020) Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study. Br J Dermatol 182(1):97–103 - PubMed - DOI`
│   inner_content: `Liyanage UE et al (2020) Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study. Br J Dermatol 182(1):97–103 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Liyanage UE et al (2020) Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study. Br J Dermatol 182(1):97–103 - PubMed - DOI`
│   │   inner_content: `Liyanage UE et al (2020) Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study. Br J Dermatol 182(1):97–103 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Millen AE et al (2004) Diet and melanoma in a case-control study. __cancer__ Epidemiol Biomark Prev 13(6):1042–1051 - DOI`
│   inner_content: `Millen AE et al (2004) Diet and melanoma in a case-control study. __cancer__ Epidemiol Biomark Prev 13(6):1042–1051 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Millen AE et al (2004) Diet and melanoma in a case-control study. `
│   │   inner_content: `Millen AE et al (2004) Diet and melanoma in a case-control study. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Epidemiol Biomark Prev 13(6):1042–1051 - DOI`
│   │   inner_content: ` Epidemiol Biomark Prev 13(6):1042–1051 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#van der Pols JC et al (2013) Vitamin D status and skin __cancer__ risk independent of time outdoors: 11-year prospective study in an Australian community. J Investig Dermatol 133(3):637–641 - PubMed - DOI`
│   inner_content: `van der Pols JC et al (2013) Vitamin D status and skin __cancer__ risk independent of time outdoors: 11-year prospective study in an Australian community. J Investig Dermatol 133(3):637–641 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `van der Pols JC et al (2013) Vitamin D status and skin `
│   │   inner_content: `van der Pols JC et al (2013) Vitamin D status and skin `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` risk independent of time outdoors: 11-year prospective study in an Australian community. J Investig Dermatol 133(3):637–641 - PubMed - DOI`
│   │   inner_content: ` risk independent of time outdoors: 11-year prospective study in an Australian community. J Investig Dermatol 133(3):637–641 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Saiag P et al (2015) Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl __cancer__ Inst 107(12):djv264 - PubMed - DOI`
│   inner_content: `Saiag P et al (2015) Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl __cancer__ Inst 107(12):djv264 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Saiag P et al (2015) Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl `
│   │   inner_content: `Saiag P et al (2015) Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Inst 107(12):djv264 - PubMed - DOI`
│   │   inner_content: ` Inst 107(12):djv264 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Muralidhar S et al (2019) Vitamin D-VDR signaling inhibits Wnt/β-catenin-mediated melanoma progression and promotes antitumor immunity. __cancer__ Res 79(23):5986–5998 - PubMed - DOI`
│   inner_content: `Muralidhar S et al (2019) Vitamin D-VDR signaling inhibits Wnt/β-catenin-mediated melanoma progression and promotes antitumor immunity. __cancer__ Res 79(23):5986–5998 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Muralidhar S et al (2019) Vitamin D-VDR signaling inhibits Wnt/β-catenin-mediated melanoma progression and promotes antitumor immunity. `
│   │   inner_content: `Muralidhar S et al (2019) Vitamin D-VDR signaling inhibits Wnt/β-catenin-mediated melanoma progression and promotes antitumor immunity. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Res 79(23):5986–5998 - PubMed - DOI`
│   │   inner_content: ` Res 79(23):5986–5998 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Becker AL et al (2021) The role of the vitamin D receptor in the pathogenesis, prognosis, and treatment of cutaneous melanoma. Front Oncol 11:743667 - PubMed - PMC - DOI`
│   inner_content: `Becker AL et al (2021) The role of the vitamin D receptor in the pathogenesis, prognosis, and treatment of cutaneous melanoma. Front Oncol 11:743667 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Becker AL et al (2021) The role of the vitamin D receptor in the pathogenesis, prognosis, and treatment of cutaneous melanoma. Front Oncol 11:743667 - PubMed - PMC - DOI`
│   │   inner_content: `Becker AL et al (2021) The role of the vitamin D receptor in the pathogenesis, prognosis, and treatment of cutaneous melanoma. Front Oncol 11:743667 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Tang JY et al (2011) Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin __cancer__: post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol 29(22):3078–3084 - PubMed - PMC - DOI`
│   inner_content: `Tang JY et al (2011) Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin __cancer__: post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol 29(22):3078–3084 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Tang JY et al (2011) Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin `
│   │   inner_content: `Tang JY et al (2011) Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol 29(22):3078–3084 - PubMed - PMC - DOI`
│   │   inner_content: `: post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol 29(22):3078–3084 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Vasilovici AF et al (2019) Vitamin D receptor polymorphisms and melanoma. Oncol Lett 17(5):4162–4169 - PubMed`
│   inner_content: `Vasilovici AF et al (2019) Vitamin D receptor polymorphisms and melanoma. Oncol Lett 17(5):4162–4169 - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Vasilovici AF et al (2019) Vitamin D receptor polymorphisms and melanoma. Oncol Lett 17(5):4162–4169 - PubMed`
│   │   inner_content: `Vasilovici AF et al (2019) Vitamin D receptor polymorphisms and melanoma. Oncol Lett 17(5):4162–4169 - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Birke M et al (2020) Association of vitamin D receptor gene polymorphisms with melanoma risk: a meta-analysis and systematic review. Anti__cancer__ Res 40(2):583–595 - PubMed - DOI`
│   inner_content: `Birke M et al (2020) Association of vitamin D receptor gene polymorphisms with melanoma risk: a meta-analysis and systematic review. Anti__cancer__ Res 40(2):583–595 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Birke M et al (2020) Association of vitamin D receptor gene polymorphisms with melanoma risk: a meta-analysis and systematic review. Anti`
│   │   inner_content: `Birke M et al (2020) Association of vitamin D receptor gene polymorphisms with melanoma risk: a meta-analysis and systematic review. Anti`
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Res 40(2):583–595 - PubMed - DOI`
│   │   inner_content: ` Res 40(2):583–595 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Samant H, Amiri HS, Zibari GB (2021) Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol 12(Suppl 2):S361–S373 - PubMed - PMC - DOI`
│   inner_content: `Samant H, Amiri HS, Zibari GB (2021) Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol 12(Suppl 2):S361–S373 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Samant H, Amiri HS, Zibari GB (2021) Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol 12(Suppl 2):S361–S373 - PubMed - PMC - DOI`
│   │   inner_content: `Samant H, Amiri HS, Zibari GB (2021) Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol 12(Suppl 2):S361–S373 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13 - PubMed - DOI`
│   inner_content: `McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13 - PubMed - DOI`
│   │   inner_content: `McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Provvisiero DP et al (2019) Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit. Sci Rep 9(1):11695 - PubMed - PMC - DOI`
│   inner_content: `Provvisiero DP et al (2019) Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit. Sci Rep 9(1):11695 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Provvisiero DP et al (2019) Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit. Sci Rep 9(1):11695 - PubMed - PMC - DOI`
│   │   inner_content: `Provvisiero DP et al (2019) Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit. Sci Rep 9(1):11695 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Huang J et al (2016) 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Mol Med Rep 13(2):1373–1380 - PubMed - DOI`
│   inner_content: `Huang J et al (2016) 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Mol Med Rep 13(2):1373–1380 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Huang J et al (2016) 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Mol Med Rep 13(2):1373–1380 - PubMed - DOI`
│   │   inner_content: `Huang J et al (2016) 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Mol Med Rep 13(2):1373–1380 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Hamilton JP et al (2014) Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma. Hepatol Res 44(13):1357–1366 - PubMed - PMC - DOI`
│   inner_content: `Hamilton JP et al (2014) Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma. Hepatol Res 44(13):1357–1366 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Hamilton JP et al (2014) Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma. Hepatol Res 44(13):1357–1366 - PubMed - PMC - DOI`
│   │   inner_content: `Hamilton JP et al (2014) Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma. Hepatol Res 44(13):1357–1366 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Chen J et al (2016) Vitamin D deficiency promotes liver tumor growth in transforming growth factor-beta/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci Rep 6:30217 - PubMed - PMC - DOI`
│   inner_content: `Chen J et al (2016) Vitamin D deficiency promotes liver tumor growth in transforming growth factor-beta/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci Rep 6:30217 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chen J et al (2016) Vitamin D deficiency promotes liver tumor growth in transforming growth factor-beta/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci Rep 6:30217 - PubMed - PMC - DOI`
│   │   inner_content: `Chen J et al (2016) Vitamin D deficiency promotes liver tumor growth in transforming growth factor-beta/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci Rep 6:30217 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Gilliland DG, Jordan CT, Felix CA (2004) The molecular basis of leukemia. Hematol Am Soc Hematol Educ Progr 2004(1):80–97 - DOI`
│   inner_content: `Gilliland DG, Jordan CT, Felix CA (2004) The molecular basis of leukemia. Hematol Am Soc Hematol Educ Progr 2004(1):80–97 - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Gilliland DG, Jordan CT, Felix CA (2004) The molecular basis of leukemia. Hematol Am Soc Hematol Educ Progr 2004(1):80–97 - DOI`
│   │   inner_content: `Gilliland DG, Jordan CT, Felix CA (2004) The molecular basis of leukemia. Hematol Am Soc Hematol Educ Progr 2004(1):80–97 - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lee HJ et al (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. __cancer__ 120(4):521–529 - PubMed - DOI`
│   inner_content: `Lee HJ et al (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. __cancer__ 120(4):521–529 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lee HJ et al (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. `
│   │   inner_content: `Lee HJ et al (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 120(4):521–529 - PubMed - DOI`
│   │   inner_content: ` 120(4):521–529 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Jackmann N et al (2020) Vitamin D status in children with leukemia, its predictors, and association with outcome. Pediatr Blood __cancer__ 67(4):e28163 - PubMed - DOI`
│   inner_content: `Jackmann N et al (2020) Vitamin D status in children with leukemia, its predictors, and association with outcome. Pediatr Blood __cancer__ 67(4):e28163 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Jackmann N et al (2020) Vitamin D status in children with leukemia, its predictors, and association with outcome. Pediatr Blood `
│   │   inner_content: `Jackmann N et al (2020) Vitamin D status in children with leukemia, its predictors, and association with outcome. Pediatr Blood `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 67(4):e28163 - PubMed - DOI`
│   │   inner_content: ` 67(4):e28163 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Wang J et al (2008) Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 283(37):25596–25605 - PubMed - DOI`
│   inner_content: `Wang J et al (2008) Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 283(37):25596–25605 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Wang J et al (2008) Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 283(37):25596–25605 - PubMed - DOI`
│   │   inner_content: `Wang J et al (2008) Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 283(37):25596–25605 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Kricker A et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J __cancer__ 122(1):144–154 - PubMed - DOI`
│   inner_content: `Kricker A et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J __cancer__ 122(1):144–154 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kricker A et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J `
│   │   inner_content: `Kricker A et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` 122(1):144–154 - PubMed - DOI`
│   │   inner_content: ` 122(1):144–154 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Shanafelt TD et al (2011) Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117(5):1492–1498 - PubMed - PMC - DOI`
│   inner_content: `Shanafelt TD et al (2011) Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117(5):1492–1498 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Shanafelt TD et al (2011) Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117(5):1492–1498 - PubMed - PMC - DOI`
│   │   inner_content: `Shanafelt TD et al (2011) Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117(5):1492–1498 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Gediz F et al (2020) A possible connection between circulating 25-hydroxy-vitamin D and molecular response in chronic myeloid leukemia. Bratisl Lek Listy 121(5):366–369 - PubMed`
│   inner_content: `Gediz F et al (2020) A possible connection between circulating 25-hydroxy-vitamin D and molecular response in chronic myeloid leukemia. Bratisl Lek Listy 121(5):366–369 - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Gediz F et al (2020) A possible connection between circulating 25-hydroxy-vitamin D and molecular response in chronic myeloid leukemia. Bratisl Lek Listy 121(5):366–369 - PubMed`
│   │   inner_content: `Gediz F et al (2020) A possible connection between circulating 25-hydroxy-vitamin D and molecular response in chronic myeloid leukemia. Bratisl Lek Listy 121(5):366–369 - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Lokeshwar BL et al (1999) Inhibition of prostate __cancer__ metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. __cancer__ Epidemiol Biomarkers Prev 8(3):241–248 - PubMed`
│   inner_content: `Lokeshwar BL et al (1999) Inhibition of prostate __cancer__ metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. __cancer__ Epidemiol Biomarkers Prev 8(3):241–248 - PubMed`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lokeshwar BL et al (1999) Inhibition of prostate `
│   │   inner_content: `Lokeshwar BL et al (1999) Inhibition of prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. `
│   │   inner_content: ` metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Epidemiol Biomarkers Prev 8(3):241–248 - PubMed`
│   │   inner_content: ` Epidemiol Biomarkers Prev 8(3):241–248 - PubMed`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Chen Y et al (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288(27):19450–19458 - PubMed - PMC - DOI`
│   inner_content: `Chen Y et al (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288(27):19450–19458 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chen Y et al (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288(27):19450–19458 - PubMed - PMC - DOI`
│   │   inner_content: `Chen Y et al (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288(27):19450–19458 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Kristal AR et al (2014) Plasma vitamin D and prostate __cancer__ risk: results from the Selenium and Vitamin E __cancer__ Prevention Trial. __cancer__ Epidemiol Biomarkers Prev 23(8):1494–1504 - PubMed - PMC - DOI`
│   inner_content: `Kristal AR et al (2014) Plasma vitamin D and prostate __cancer__ risk: results from the Selenium and Vitamin E __cancer__ Prevention Trial. __cancer__ Epidemiol Biomarkers Prev 23(8):1494–1504 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kristal AR et al (2014) Plasma vitamin D and prostate `
│   │   inner_content: `Kristal AR et al (2014) Plasma vitamin D and prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` risk: results from the Selenium and Vitamin E `
│   │   inner_content: ` risk: results from the Selenium and Vitamin E `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Prevention Trial. `
│   │   inner_content: ` Prevention Trial. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Epidemiol Biomarkers Prev 23(8):1494–1504 - PubMed - PMC - DOI`
│   │   inner_content: ` Epidemiol Biomarkers Prev 23(8):1494–1504 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Jiang X et al (2019) Circulating vitamin D concentrations and risk of breast and prostate __cancer__: a Mendelian randomization study. Int J Epidemiol 48(5):1416–1424 - PubMed - DOI`
│   inner_content: `Jiang X et al (2019) Circulating vitamin D concentrations and risk of breast and prostate __cancer__: a Mendelian randomization study. Int J Epidemiol 48(5):1416–1424 - PubMed - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Jiang X et al (2019) Circulating vitamin D concentrations and risk of breast and prostate `
│   │   inner_content: `Jiang X et al (2019) Circulating vitamin D concentrations and risk of breast and prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: `: a Mendelian randomization study. Int J Epidemiol 48(5):1416–1424 - PubMed - DOI`
│   │   inner_content: `: a Mendelian randomization study. Int J Epidemiol 48(5):1416–1424 - PubMed - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Albanes D et al (2011) Serum 25-hydroxy vitamin D and prostate __cancer__ risk in a large nested case-control study. __cancer__ Epidemiol Biomarkers Prev 20(9):1850–1860 - PubMed - PMC - DOI`
│   inner_content: `Albanes D et al (2011) Serum 25-hydroxy vitamin D and prostate __cancer__ risk in a large nested case-control study. __cancer__ Epidemiol Biomarkers Prev 20(9):1850–1860 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Albanes D et al (2011) Serum 25-hydroxy vitamin D and prostate `
│   │   inner_content: `Albanes D et al (2011) Serum 25-hydroxy vitamin D and prostate `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` risk in a large nested case-control study. `
│   │   inner_content: ` risk in a large nested case-control study. `
│   ├── BoldNode
│   │   full_match: `__cancer__`
│   │   inner_content: `cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `cancer`
│   │   │   inner_content: `cancer`
│   ├── TextNode
│   │   full_match: ` Epidemiol Biomarkers Prev 20(9):1850–1860 - PubMed - PMC - DOI`
│   │   inner_content: ` Epidemiol Biomarkers Prev 20(9):1850–1860 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Protiva P et al (2016) Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial. Am J Clin Nutr 103(5):1224–1231 - PubMed - PMC - DOI`
│   inner_content: `Protiva P et al (2016) Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial. Am J Clin Nutr 103(5):1224–1231 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Protiva P et al (2016) Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial. Am J Clin Nutr 103(5):1224–1231 - PubMed - PMC - DOI`
│   │   inner_content: `Protiva P et al (2016) Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial. Am J Clin Nutr 103(5):1224–1231 - PubMed - PMC - DOI`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Mol Oncol 5(2):197–214 - PubMed - PMC - DOI`
│   inner_content: `Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Mol Oncol 5(2):197–214 - PubMed - PMC - DOI`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Mol Oncol 5(2):197–214 - PubMed - PMC - DOI`
│   │   inner_content: `Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Mol Oncol 5(2):197–214 - PubMed - PMC - DOI`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Cancer)) category contains:`
│   inner_content: `VitaminDWiki – ((Cancer)) category contains:`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Cancer))`
│   │   inner_content: `Cancer`
│   │   page: `Cancer`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Cancer`
│   │   │   inner_content: `Cancer`
│   ├── TextNode
│   │   full_match: ` category contains:`
│   │   inner_content: ` category contains:`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Cancer&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Cancer&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Cancer
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── TextNode
│   full_match: `\n`
│   inner_content: `\n`

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!Vitamin D and potential effects on cancers: a review
Mol Biol Rep. 2024 Jan 25;51(1):190. doi: 10.1007/s11033-023-09111-y 
PDF is behind a paywall.  Can be viewed at [https://www.deepdyve.com/lp/springer-journals/vitamin-d-and-potential-effects-on-cancers-a-review-BWuTgsGEGc?articleList=%2Fsearch%3Fquery%3D%2522Vitamin%2BD%2522%26articleFilter%3Drentable%257Cfree%257Crestricted%26dateFrom%3D2024-01-01%26page%3D2|DeepDyve]
Pouria Sobhi 1, Mohammad Bahrami 1, Faraz Mahdizadeh 1, Aliakbar Fazaeli 2, Ghader Babaei 3, Lotfollah Rezagholizadeh 4

__Vitamin D is common to 4 concerns__
{img type=&quot;attId&quot; attId=&quot;20741&quot; width=&quot;400&quot;}
Cancer is characterized by the abnormal and uncontrollable division and growth of cells that can infiltrate tissues and alter normal physiological function, which will become crucial and life-threatening if left untreated. Cancer can be a result of genetics, such as mutations or environmental causes, including smoking, lack of physical activity, as well as nutritional imbalance in the body. Vitamin D is one of the foremost nutrients that play a crucial role in a variety of biochemical pathways, and it is an important key factor in several diseases. Vitamin D is an essential nutrient for preventing malignancies and a complementary treatment for cancer through direct and indirect biochemical pathways. In this article, we summarized the correlation between vitamin D and various cancers using an extensive search on PubMed, Google Scholar, and Scopus. This paper reviews the role of vitamin D in different types of cancer.
---
!!!!!99 References
#Christakos S et al (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39(2):243–253 (table of contents) - PubMed - PMC - DOI
#Carlberg C (2019) Vitamin D: a micronutrient regulating genes. Curr Pharm Des 25(15):1740–1746 - PubMed - DOI
#Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523(1):123–133 - PubMed - DOI
#Akimbekov NS et al (2022) Vitamin D and phosphate interactions in health and disease. Adv Exp Med Biol 1362:37–46 - PubMed - DOI
#Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930 - PubMed - DOI
#Chang EM et al (2014) Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab 99(7):2526–2532 - PubMed - DOI
#Zanatta L et al (2011) Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D3 in rat testis. Life Sci 89(15–16):515–523 - PubMed - DOI
#Zhao D et al (2017) Serum vitamin D and sex hormones levels in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA). Maturitas 96:95–102 - PubMed - DOI
#Bergengren O et al (2023) 2022 update on prostate __cancer__ epidemiology and risk factors—a systematic review. Eur Urol 84(2):191–206 - PubMed - DOI
#Song ZY et al (2018) Circulating vitamin D level and mortality in prostate __cancer__ patients: a dose-response meta-analysis. Endocr Connect 7(12):R294–R303 - PubMed - PMC - DOI
#Capiod T et al (2018) Do dietary calcium and vitamin D matter in men with prostate __cancer__? Nat Rev Urol 15(7):453–461 - PubMed - DOI
#Bao BY, Yeh SD, Lee YF (2006) 1alpha,25-dihydroxyvitamin D3 inhibits prostate __cancer__ cell invasion via modulation of selective proteases. Carcinogenesis 27(1):32–42 - PubMed - DOI
#Woo TC et al (2005) Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr __cancer__ 51(1):32–36 - PubMed - DOI
#Bernichtein S et al (2017) Vitamin D3 prevents calcium-induced progression of early-stage prostate tumors by counteracting TRPC6 and calcium sensing receptor upregulation. __cancer__ Res 77(2):355–365 - PubMed - DOI
#Barreto AM et al (2000) 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. __cancer__ Epidemiol Biomarkers Prev 9(3):265–270 - PubMed
#Gupta D et al (2009) Vitamin D and prostate __cancer__ risk: a review of the epidemiological literature. Prostate __cancer__ Prostatic Dis 12(3):215–226 - PubMed - DOI
#Tuohimaa P et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate __cancer__ risk: a longitudinal, nested case-control study in the Nordic countries. Int J __cancer__ 108(1):104–108 - PubMed - DOI
#Gao J et al (2018) Circulating vitamin D concentration and risk of prostate __cancer__: a dose-response meta-analysis of prospective studies. Ther Clin Risk Manag 14:95–104 - PubMed - PMC - DOI
#Wilkinson L, Gathani T (2022) Understanding breast __cancer__ as a global health concern. Br J Radiol 95(1130):20211033 - PubMed - DOI
#Mittal MK et al (2008) In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 372(1):30–34 - PubMed - PMC - DOI
#Liu X et al (2018) miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast __cancer__. Oncogene 37(25):3426–3439 - PubMed - DOI
#Larriba MJ, Garcia de Herreros A, Munoz A (2016) Vitamin D and the epithelial to mesenchymal transition. Stem Cells Int 2016:6213872 - PubMed - PMC - DOI
#Lopes N et al (2012) 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast __cancer__ cells by CDH1-promoter demethylation. Anti__cancer__ Res 32(1):249–257 - PubMed
#Wilmanski T et al (2016) 1alpha,25-dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231 cells in an in vitro model of breast to bone metastasis. Nutr __cancer__ 68(7):1202–1209 - PubMed - PMC - DOI
#Koli K, Keski-Oja J (2000) 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11(4):221–229 - PubMed
#Li J et al (2021) Vitamin D regulates CXCL12/CXCR4 and epithelial-to-mesenchymal transition in a model of breast __cancer__ metastasis to lung. Endocrinology. https://doi.org/10.1210/endocr/bqab049 - DOI - PubMed - PMC
#Anisiewicz A et al (2018) Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland __cancer__. Int J Oncol 52(1):103–126 - PubMed
#Anisiewicz A et al (2019) Calcitriol analogues decrease lung metastasis but impair bone metabolism in aged ovariectomized mice bearing 4T1 mammary gland tumours. Aging Dis 10(5):977–991 - PubMed - PMC - DOI
#Vanhevel J et al (2022) The role of vitamin D in breast __cancer__ risk and progression. Endocr Relat __cancer__ 29(2):R33–R55 - PubMed - DOI
#Filip-Psurska B et al (2022) Vitamin D, Th17 lymphocytes, and breast __cancer__. __cancer__s 14(15):3649 - PubMed - PMC - DOI
#Krishnan AV et al (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast __cancer__ therapy. Endocrinology 151(1):32–42 - PubMed - DOI
#Swami S et al (2011) Inhibitory effects of calcitriol on the growth of MCF-7 breast __cancer__ xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm __cancer__ 2(3):190–202 - PubMed - PMC - DOI
#Vink-van Wijngaarden T et al (1994) Inhibition of breast __cancer__ cell growth by combined treatment with vitamin D3 analogues and tamoxifen. __cancer__ Res 54(21):5711–5717 - PubMed
#Lim ST et al (2018) Synergistic anti__cancer__ effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast __cancer__ cells. Mol Med Rep 17(4):5581–5588 - PubMed - PMC
#Friedrich M et al (2018) Effects of combined treatment with vitamin D and COX2 inhibitors on breast __cancer__ cell lines. Anti__cancer__ Res 38(2):1201–1207 - PubMed
#Segovia-Mendoza M et al (2017) The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast __cancer__ cells. Am J __cancer__ Res 7(7):1486–1500 - PubMed - PMC
#Tavera-Mendoza LE et al (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast __cancer__ cells. Proc Natl Acad Sci USA 114(11):E2186–E2194 - PubMed - PMC - DOI
#Estebanez N et al (2018) Vitamin D exposure and Risk of Breast __cancer__: a meta-analysis. Sci Rep 8(1):9039 - PubMed - PMC - DOI
#Song D et al (2019) Vitamin D intake, blood vitamin D levels, and the risk of breast __cancer__: a dose-response meta-analysis of observational studies. Aging 11(24):12708–12732 - PubMed - PMC - DOI
#Vaughan-Shaw PG et al (2017) The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on __cancer__ outcome: systematic review and meta-analysis. Br J __cancer__ 116(8):1092–1110 - PubMed - PMC - DOI
#Hossain S et al (2019) Vitamin D and breast __cancer__: a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 30:170–184 - PubMed - PMC - DOI
#Crew KD et al (2019) Randomized double-blind placebo-controlled biomarker modulation study of vitamin D supplementation in premenopausal women at high risk for breast __cancer__ (SWOG S0812). __cancer__ Prev Res 12(7):481–490 - DOI
#Crew KD et al (2009) Association between plasma 25-hydroxyvitamin D and breast __cancer__ risk. __cancer__ Prev Res 2(6):598–604 - DOI
#Qin B et al (2020) Intake of vitamin D and calcium, sun exposure, and risk of breast __cancer__ subtypes among black women. Am J Clin Nutr 111(2):396–405 - PubMed - DOI
#Manson JE et al (2019) Vitamin D supplements and prevention of __cancer__ and cardiovascular disease. N Engl J Med 380(1):33–44 - PubMed - DOI
#Chandler PD et al (2020) Effect of vitamin D3 supplements on development of advanced __cancer__: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850 - PubMed - PMC - DOI
#Lappe J et al (2017) Effect of vitamin D and calcium supplementation on __cancer__ incidence in older women: a randomized clinical trial. JAMA 317(12):1234–1243 - PubMed - DOI
#Scragg RKR (2019) Overview of results from the Vitamin D assessment (ViDA) study. J Endocrinol Investig 42(12):1391–1399 - DOI
#Arnaout A et al (2019) Randomized window of opportunity trial evaluating high-dose vitamin D in breast __cancer__ patients. Breast __cancer__ Res Treat 178(2):347–356 - PubMed - DOI
#Li Z et al (2021) Effect of vitamin D supplementation on risk of breast __cancer__: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 8:655727 - PubMed - PMC - DOI
#Voutsadakis IA (2021) Vitamin D baseline levels at diagnosis of breast __cancer__: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 14(1):16–26 - PubMed - DOI
#O’Brien KM et al (2018) Vitamin D, DNA methylation, and breast __cancer__. Breast __cancer__ Res 20(1):70 - PubMed - PMC - DOI
#Simmons KM et al (2015) Gene signatures of 1,25-dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem 116(8):1693–1711 - PubMed - PMC - DOI
#O’Brien KM et al (2022) Vitamin D supplement use and risk of breast __cancer__ by race-ethnicity. Epidemiology 33(1):37–47 - PubMed - PMC - DOI
#Sheng L, Callen DF, Turner AG (2018) Vitamin D(3) signaling and breast __cancer__: insights from transgenic mouse models. J Steroid Biochem Mol Biol 178:348–353 - PubMed - DOI
#Bauer SR et al (2013) Plasma vitamin D levels, menopause, and risk of breast __cancer__: dose-response meta-analysis of prospective studies. Medicine 92(3):123–131 - PubMed - PMC - DOI
#Lewandowska A et al (2022) Risk factors for the diagnosis of colorectal __cancer__. Cancer Control 29:10732748211056692 - PubMed - PMC - DOI
#Klampfer L (2014) Vitamin D and colon __cancer__. World J Gastrointest Oncol 6(11):430–437 - PubMed - PMC - DOI
#Ferrer-Mayorga G et al (2019) Mechanisms of action of vitamin D in colon __cancer__. J Steroid Biochem Mol Biol 185:1–6 - PubMed - DOI
#Khayami R et al (2022) Epigenomic effects of vitamin D in colorectal __cancer__. Epigenomics 14(19):1213–1228 - PubMed - DOI
#Huang CY et al (2022) Bioactive vitamin D attenuates MED28-mediated cell growth and epithelial-mesenchymal transition in human colorectal __cancer__ cells. Biomed Res Int 2022:2268818 - PubMed - PMC - DOI
#Varghese JE (2020) Role of vitamin D3 on apoptosis and inflammatory-associated gene in colorectal __cancer__: an in vitro approach. J King Saud Univ Sci 32(6):2786–2789 - DOI
#Lamprecht SA, Lipkin M (2003) Chemoprevention of colon __cancer__ by calcium, vitamin D and folate: molecular mechanisms. Nat Rev __cancer__ 3(8):601–614 - PubMed - DOI
#Timar J, Ladanyi A (2022) Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci 23(10):5384 - PubMed - PMC - DOI
#Branisteanu DE et al (2023) Differences and similarities in epidemiology and risk factors for cutaneous and uveal melanoma. Medicina 59(5):943 - PubMed - PMC - DOI
#Zhou M et al (2016) Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387(10015):251–272 - PubMed - DOI
#Veierod MB et al (2010) Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. __cancer__ Epidemiol Biomarkers Prev 19(1):111–120 - PubMed - DOI
#Gajos-Michniewicz A, Czyz M (2020) WNT signaling in melanoma. Int J Mol Sci 21(14):4852 - PubMed - PMC - DOI
#Holstein TW (2012) The evolution of the Wnt pathway. Cold Spring Harb Perspect Biol 4(7):a007922 - PubMed - PMC - DOI
#Chaiprasongsuk A et al (2019) Protective effects of novel derivatives of vitamin D(3) and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms. Redox Biol 24:101206 - PubMed - PMC - DOI
#Liyanage UE et al (2020) Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study. Br J Dermatol 182(1):97–103 - PubMed - DOI
#Millen AE et al (2004) Diet and melanoma in a case-control study. __cancer__ Epidemiol Biomark Prev 13(6):1042–1051 - DOI
#van der Pols JC et al (2013) Vitamin D status and skin __cancer__ risk independent of time outdoors: 11-year prospective study in an Australian community. J Investig Dermatol 133(3):637–641 - PubMed - DOI
#Saiag P et al (2015) Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl __cancer__ Inst 107(12):djv264 - PubMed - DOI
#Muralidhar S et al (2019) Vitamin D-VDR signaling inhibits Wnt/β-catenin-mediated melanoma progression and promotes antitumor immunity. __cancer__ Res 79(23):5986–5998 - PubMed - DOI
#Becker AL et al (2021) The role of the vitamin D receptor in the pathogenesis, prognosis, and treatment of cutaneous melanoma. Front Oncol 11:743667 - PubMed - PMC - DOI
#Tang JY et al (2011) Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin __cancer__: post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol 29(22):3078–3084 - PubMed - PMC - DOI
#Vasilovici AF et al (2019) Vitamin D receptor polymorphisms and melanoma. Oncol Lett 17(5):4162–4169 - PubMed
#Birke M et al (2020) Association of vitamin D receptor gene polymorphisms with melanoma risk: a meta-analysis and systematic review. Anti__cancer__ Res 40(2):583–595 - PubMed - DOI
#Samant H, Amiri HS, Zibari GB (2021) Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol 12(Suppl 2):S361–S373 - PubMed - PMC - DOI
#McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13 - PubMed - DOI
#Provvisiero DP et al (2019) Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit. Sci Rep 9(1):11695 - PubMed - PMC - DOI
#Huang J et al (2016) 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Mol Med Rep 13(2):1373–1380 - PubMed - DOI
#Hamilton JP et al (2014) Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma. Hepatol Res 44(13):1357–1366 - PubMed - PMC - DOI
#Chen J et al (2016) Vitamin D deficiency promotes liver tumor growth in transforming growth factor-beta/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci Rep 6:30217 - PubMed - PMC - DOI
#Gilliland DG, Jordan CT, Felix CA (2004) The molecular basis of leukemia. Hematol Am Soc Hematol Educ Progr 2004(1):80–97 - DOI
#Lee HJ et al (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. __cancer__ 120(4):521–529 - PubMed - DOI
#Jackmann N et al (2020) Vitamin D status in children with leukemia, its predictors, and association with outcome. Pediatr Blood __cancer__ 67(4):e28163 - PubMed - DOI
#Wang J et al (2008) Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 283(37):25596–25605 - PubMed - DOI
#Kricker A et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J __cancer__ 122(1):144–154 - PubMed - DOI
#Shanafelt TD et al (2011) Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117(5):1492–1498 - PubMed - PMC - DOI
#Gediz F et al (2020) A possible connection between circulating 25-hydroxy-vitamin D and molecular response in chronic myeloid leukemia. Bratisl Lek Listy 121(5):366–369 - PubMed
#Lokeshwar BL et al (1999) Inhibition of prostate __cancer__ metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. __cancer__ Epidemiol Biomarkers Prev 8(3):241–248 - PubMed
#Chen Y et al (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288(27):19450–19458 - PubMed - PMC - DOI
#Kristal AR et al (2014) Plasma vitamin D and prostate __cancer__ risk: results from the Selenium and Vitamin E __cancer__ Prevention Trial. __cancer__ Epidemiol Biomarkers Prev 23(8):1494–1504 - PubMed - PMC - DOI
#Jiang X et al (2019) Circulating vitamin D concentrations and risk of breast and prostate __cancer__: a Mendelian randomization study. Int J Epidemiol 48(5):1416–1424 - PubMed - DOI
#Albanes D et al (2011) Serum 25-hydroxy vitamin D and prostate __cancer__ risk in a large nested case-control study. __cancer__ Epidemiol Biomarkers Prev 20(9):1850–1860 - PubMed - PMC - DOI
#Protiva P et al (2016) Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial. Am J Clin Nutr 103(5):1224–1231 - PubMed - PMC - DOI
#Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Mol Oncol 5(2):197–214 - PubMed - PMC - DOI
---
!!!!VitaminDWiki – ((Cancer)) category contains:
{include page=&quot;Cancer&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}

</code>
</pre></article></div></div><script src="/js/lightspa.js?v=1748177531"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1748177531",indexUrl:"/search/search_index.json.gz?v=1748177531"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1748177531"></script><script src="/js/search-results-panel.js?v=1748177531"></script><script src="/js/tiki-redirects.js?v=1748177531"></script></body></html>